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Abstract 
 
 
Because of long-range transport, the Arctic is chronically exposed to persistent organic 
pollutants (POPs), such as polychlorinated biphenyls (PCBs), pesticides and brominated 
flame retardants, such as polybrominated flame retardants (PBDEs). Because of POPs are 
persistent and lipofilic, they are bioaccumulated in lipids and biomagnified in the food 
chains. The structures of some POPs resemble endogenous hormones, and have been shown 
to disrupt the TH homeostasis in animals. It has also been reported that POPs may affect the 
levels of vitamin D in seals, and thereby possibly disturb the calcium homeostasis and bone 
metabolism. The polar bear (Ursus maritimus) is a top predator in the Arctic and is exposed 
to high levels of POPs through its diet. However, the polar bear has a very good capacity to 
biotransform (metabolize) POPs, and because of the restrictions in the use of industrial 
chemicals and pesticides, the levels of POPs in polar bears from Svalbard have decreased 
during the last ten years. Still, polar bears have the potential to accumulate high levels of the 
most persistent congeners of PCBs.  
 
The aim of this study was to investigate the combined interactive influences of POPs and 
thyroid hormones (THs: free T4 [FT4], total T4 [TT4], free T3 [FT3], total T3 [TT3]) on 
1,25-dihydroxyvitamin D3 (1,25(OH)2D) in two groups of female polar bears in different 
physiologic status, (females with cubs of the year [FWCOY] and females without cubs of the 
year [FWOCOY]) and in males. Blood samples from eight FWCOY, 15 FWOCOY and 20 
males were obtained from the population at Svalbard, Norway, in April and May of 2008. 
Plasma concentrations of 1,25(OH)2D and THs were analysed by radioimmunoassay. Plasma 
concentrations of POPs were analysed using gas chromatography-mass spectrophotometry 
(GC-MS). Levels of 1,25(OH)2D, was examined in relation to contaminant load, biological 
and environmental factors by the use of principle component analysis (PCA),  orthogonal 
projections to latent structures (OPLS) analysis, analysis of variance (ANOVA) and 
Pearson´s and Spearman´s rank correlation tests.  
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Levels of 1,25(OH)2D did not differ significantly between the three groups of adult polar 
bears. In FWCOY, both multivariate data analysis and bivariate correlation tests indicated 
positive relationships between plasma levels of 1,25(OH)2D and plasma levels of THs (FT3, 
FT3:TT3, FT4 and TT4), age and biometric variables (zygomatic width).  Negative 
relationships were indicated between levels of 1,25(OH)2D and two POPs (HCB and BDE-
153). For FWOCOY, there were indicated positive relationships between 1,25(OH)2D and 
mainly OH-PCBs, but also PCBs, PBDEs and pesticides seemed to be positively related to 
1,25(OH)2D levels. In contrast, one PBDE was negatively related to 1,25(OH)2D, but this 
compund was suspected to have high background levels. Thus, this particular relationship 
should be considered weak/semi-quantitative. None of the THs or the biometric variables 
were related to 1,25(OH)2D levels in FWOCOY. However, it should be noted that in 
FWOCOY, the OPLS model was relatively weak, with fairly low explained variance. In 
males, both multivariate data analysis and bivariate correlation tests indicated positive 
relationships between 1,25(OH)2D levels and THs (TT3 and TT4). Although in males the 
multivariate data analysis indicated that several of the contaminant compounds and some of 
the biometric variables were related to 1,25(OH)2D levels, the bivariate correlation tests did 
not support that. It should also be noted that the OPLS model for males was weak, with low 
explained variance and low predictability. Thus, for males, no final conclusion can be drawn 
based on the model.  
 
The results suggests possible vitamin D endocrine disrupting effects of mainly OH-PCBs on 
the most active metabolite of vitamin D3, 1,25(OH)2D. The results also indicate that there 
may be combined (interactive) effects of POPs and THs on plasma levels of 1,25(OH)2D in 
polar bears. Because of the dominance of OH-PCBs in the plasma of both female and male 
polar bears, and their known thyroid hormone disrupting effects, the potential disrupting 
effects of OH-PCBs on the vitamin D endocrine system indicated in this thesis, suggest the 
need for further research. 
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Abbreviations 
 
 
 
AG   Axillary girth 
ANOVA  Analysis of variance 
 
BCI   Body condition index 
BM   Body mass 
 
CV   Coefficient of Variation 
CV-ANOVA  Cross validated analysis of variance 
 
DDE   Dichlorodiphenyldichloroethylene 
DDT   Dichlorodiphenyltrichloroethane 
df   Degrees of freedom 
 
EDC   Endocrine disrupting chemicals 
 
FT3   Free triiodothyronine 
FT4   Free thyroxine 
FWCOY  Females with cubs of the year 
FWOCOY  Females without cubs of the year 
 
GC   Gas chromatograph 
 
HCB   Hexachlorobenzene 
HCH   Hexachlorocyclohexane 
HL   Head length 
HPT   Hypothalamic-pituitary-thyroid axis 
 
ID   Identification number 
IUPAC  International Union of Pure and Applied Chemistry 
 
LOD   Limit of detection 
 
MS   Mass spectrometer 
 
N   Number of observations 
NTNU   Norwegian University of Science and Technology 
 
OH-PCBs  Hydroxylated polychlorinated biphenyls 
 
OPLS   Orthogonal projection to latent structures 
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p   Probability of rejecting the hypothesis 
 
PBDEs  Polybrominated diphenyl ethers 
PC   Principal component 
PCA   Principal component analysis 
PCBs   Polychlorinated biphenyls 
PLS   Projection to latent structures 
POPs   Persistent organic pollutants 
 
Q2   Goodness of prediction coefficient 
 
r   Correlation coefficient 
RIA   Radioimmunoassay 
R2X   Explained variance 
R2Y   Goodness of fit, correlation coefficient 
RPM   Rounds per minute 
 
SD   Standard deviation 
SL   Straight length 
 
TBM   Total body mass 
TH   Thyroid hormone 
TT3   Total triiodothyronine 
TT4   Total thyroxine 
TSH   Thyroid stimulating hormone 
 
UV   Unit variance 
VIP   Variables importance in projections 
 
w.w   Wet weight 
 
ZW   Zygomatic width 
 
1,25(OH)2D  1,25-dihydroxyvitamin D3 (calcitriol) 
25(OH)D3  25-hydroxyvitamin D3 (calcifediol) 
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1. Introduction 
 
 
 
Due to long-range transportation with air and ocean currents, persistent organic pollutants 
(POPs) such as polychlorinated biphenyls (PCBs) and others, biomagnify in the Arctic 
marine foodweb (Bustnes et al., 2010). As a result of their physiochemical properties, the 
POPs are resistant to biodegradation and will accumulate in wildlife (AMAP, 1998, Wania & 
Mackay, 1995). The Arctic wildlife is exposed to varying levels of natural stress due to the 
fluctuating external conditions (e.g. temperature, food-availability, sea-ice contidions). There 
has been detected high levels of POPs in the polar bear (Ursus maritimus) at Svalbard 
(Bernhoft et al., 1997). Thus, in addition to natural stress, polar bears are affected by 
anthropogenic stressors, such as POPs (Bustnes et al., 2008, Jenssen, 2006). 
 
 
1.1 Persistent organic pollutants 
 
POPs are mainly manufactured chemicals (e.g. PCBs), byproducts of industrial processes 
(e.g. hexachlorobenzene (HCB)), or pesticides (e.g. dichlorodiphenyltrichloroethanes (DDT), 
chlordane) (de March et al., 1998). There have been a decreasing trend in levels of legacy 
POPs in the Arctic biota during the last decade, a result of restrictions in production and use 
of industrial chemicals and pesticides from the 1970s up to now (Braune et al., 2005, Bustnes 
et al., 2010). However, it should be noted that several novel classes of POPs, such as 
brominated flame retardants (BFRs) and perflouralkyl substances (PFASs), are detected in 
increasing levels in Arctic biota (de Wit et al., 2010). Since POPs have toxic and endocrine 
disruptive effects (Jones & De Voogt, 1999, Letcher et al., 2010), there is an increasing 
concern about the effects of these compounds on the health of Arctic wildlife.  
 
Although POPs are diverse with respect to their chemical structures, most of them have some 
elements in common, such as halogenated aromatic or aliphatic rings. They also share some 
typical physiochemical properties, like that they are highly lipophile, have relatively low 
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vapor pressure, that means they are semi-volatile, and they are resistant to biodegradation 
(AMAP, 1998, Borgå et al., 2004, Diamanti-Kandarakis et al., 2009). This explains why 
POPs are found in the Arctic, far away from the production or emission sources. Their 
lipophilicity and resistance to biodegradation make them bioaccumulate in Arctic animals,  
that generally have high lipid contents, such as seals, and POPs follow the lipid transfer from 
prey to consumer, a process called biomagnification (Borgå et al., 2004, de March et al., 
1998). This, in addition to several biological factors such as trophic position, age, condition, 
body size, and seasonality, which also may affect the bioaccumulation and trophic transfer of 
POPs in the Arctic marine food web, leads to high concentrations in long-lived animals on 
top of the food chain, such as polar bears and glaucous gulls (Larus hyperboreus) (Borgå et 
al., 2004, Hop et al., 2002, Kelly et al., 2007, Letcher et al., 2010).  
 
Polar bears are particularly vulnerable because their diet consist mainly of seal blubber, and 
especially the highly chlorinated PCBs are found to accumulate in polar bears and 
particularly in males (Bernhoft et al., 1997, Letcher et al., 1998). However, food web 
magnification depends on the individual species ability to biotransform POPs to more 
hydrophilic compounds, which are more readily eliminated (Hop et al., 2002, Kelly et al., 
2007). Adult polar bears have an effective cytochrome P450 system and can therefore 
metabolize many of the POPs they ingest from their diet, such as most of the PCB congeners 
and DDT and its metabolites. The most persistent congeners of PCB can nevertheless reach 
very high concentrations (Bernhoft et al., 1997, Letcher et al., 1998).  
 
 
1.2   Endocrine disruption 
 
The ability that some POPs have to interfere with the endogenous hormone system in 
organisms is a process called endocrine disruption. Especially the conflict between POPs and 
the sex hormones or the thyroid hormones (THs) has received considerable attention the 
recent years (Diamanti-Kandarakis et al., 2009). Endocrine disrupting chemicals (EDCs) are 
chemicals that may bind to, or block, hormone receptors, alter synthesis, transport, or the 
metabolism of hormones, or interfere with signalling pathways of the hypothalamus-
pituitary-endocrine gland axis (Dawson, 2000). The result of EDC activity is a change in the 
hormonal system that may disrupt the organisms ability to communicate with, and respond to 
its environment (Diamanti-Kandarakis et al., 2009).   
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It is also suggested that POPs can cause adverse effects on vitamin status, immune system, 
organ morphology and behaviour (Haave et al., 2003, Murvoll et al., 2005, Olsen et al., 2003, 
Routti et al., 2008, Skaare et al., 2001, Wiig et al., 1998).  
 
 
1.2.1 Vitamin D 
 
The vitamin D endocrine system plays an essential role in calcium homeostasis and bone 
metabolism. Cholecalciferol, or vitamin D3, which is categorized as a hormone rather than a 
vitamin (Horst et al., 2005), is either absorbed in the intestine from dietary uptake, or 
produced in the skin from 7-dehydrocholesterol (Figure 1). First it is metabolized in the liver, 
to calcifediol (also called 25-hydroxyvitamin D3 (25(OH)D)) an then further in the kidney to 
calcitriol (also called 1,25-dihydroxyvitamin D3 (1,25(OH)2D)), the most active metabolite 
of vitamin D3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Vitamin D3 is synthesized from 7-dehydrocholesterol, a derivative of cholesterol, which is then 
photolyzed by ultraviolet light. The product is Previtamin D3, which spontaneously isomerizes to Vitamin D3 
(cholecalciferol). Vitamin D3 is then hydroxylated in the liver to 25-hydroxycholecalciferol (calcifediol) and 
stored until it is needed. 25-hydroxycholecalciferol is further hydroxylated in the kidneys to the main 
biologically active form 1,25-dihydroxycholecalciferol (calcitriol) (Vieth, 2005) 
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Together with parathyroid hormone and calcitonin, 1,25(OH)2D plays a major role in 
regulating serum calcium homeostasis (Vieth, 2005). A physiological level of 1,25(OH)2D 
stimulates intestinal absorption and renal reabsorption of calcium and phosphate, which 
further stimulates bone mineralization (Yasuda et al., 2005). Low levels of 1,25(OH)2D may 
therefore cause disruption of bone mineralization (Baylink et al., 1970, Faibish & Boskey, 
2005). In a study conducted on Baltic grey seals (Halichoerus grypus), high levels of POPs 
were associated with deficiencies in bone structure, such as scull lesions (Bergman et al., 
1992) and decreased bone density (Lind et al., 2003). Sonne et al (2006) also reported 
negative relationships between POPs and testis lenght and baculum bone mineral densities in 
male polar bears from East Greenland, and also between POPs and ovary lenght/weight and 
uterine horn lenght in females, which might pose a risk to the population regarding 
reproduction. Few studies have investigated contaminant effects on the vitamin D status, but 
in one study conducted with PCB-exposed rodents (Lilienthal et al., 2000), decreased levels 
of vitamin D3 metabolites were detected.  Therefore it is possible that the bone disorders 
observed in seals and polar bears may be related to POP-induced effects on vitamin D 
homeostasis. According to another study by Routti et al. (2008), bone-related parameters and 
thyroid homeostasis may be disturbed by contaminants, because they might depress 
circulating 1,25(OH)2D levels; however 1,25(OH)2D deficiency could be compensated for by 
elevated TH levels to maintain serum calcium concentration (Mohan et al., 2004, Routti et 
al., 2008). 
 
1.2.2 Thyroid hormones 
 
All vertebrates are dependent on an appropriate production and function of thyroid hormones 
(THs) to achieve a normal development and physiological function (Yen & Chin, 1994). In 
mammals the THs control the thermoregulation, body mass, growth, lipid metabolism, 
reproduction, and secondary sex characteristics (Merryman & Buckles, 1998). The structure 
and mechanism by which THs are synthesized are the same among vertebrate species. The 
thyroid gland which is part of the hypothalamic-pituitary-thyroid axis (HPT), produces  and 
releases thyroxine (T4), when stimulated by thyroid stimulating hormone (TSH), released 
from the pituitary. Further T4 is deiodinized mainly in the liver to triiodothyronine (T3), the 
most active TH (McNabb, 1992). Most of the circulating THs are associated with binding 
proteins. Several environmental contaminants have a high degree of structural similarity to 
the THs, and may interfere with the binding of THs to receptors or transport proteins, the 
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metabolism of THs, or affect the biosynthesis (Boas et al., 2006, Diamanti-Kandarakis et al., 
2009, Routti et al., 2008, Zoeller, 2007). Several interactions have been discovered among 
toxic chemicals and the thyroid hormone system. The reported effects have been abnormal 
thyroid gland structure and altered levels of THs after exposure to POPs or their metabolites. 
The effects have been observed in a number of species (e.g. glaucous gulls (Verreault et al., 
2004, Verreault et al., 2007), polar bears (Braathen et al., 2004, Skaare et al., 2001), gray seal 
pups (Sørmo et al., 2005) and rodents (Kato et al., 2010)).  
 
 
1.3   The polar bears  
 
The polar bear is the top predator in the Arctic food web. Their diet consist mainly of ringed 
seal (Phoca hispida), but also of bearded seal (Erignathus barbatus) and harp seal (Phoca 
groenlandicus) (Derocher et al., 2002). As their diet is lipid rich because of their large 
consumption of seal blubber, concern exist of potential health effects due to long-life 
exposure to high concentrations of POPs (Braathen et al., 2004, Bytingsvik et al., 2012, 
Oskam et al., 2003). Possible disturbances in thyroid hormone homeostasis have been 
reported in polar bears from Svalbard (Braathen et al., 2004). There is also concern about the 
possible reproductive effects in polar bears, due to reported negative correlations between 
environmental contaminants and sex hormones found in both male (Oskam et al., 2003) and 
female polar bears (Haave et al., 2003) at Svalbard. Furthermore possible effects on polar 
bears immune and vitamin system have been reported (Lie et al., 2004, Skaare et al., 2001). It 
is reasonable to believe that male polar bears will achieve higher levels of persistent 
contaminants than females with age, due to maternal transfer of lipophilic compounds from 
mother to offspring during lactation (Bernhoft et al., 1997, Bytingsvik et al., 2012).  
 
 
1.4   Objectives 
 
The main objectives of the study was to examine if the levels and prevalence of POPs (PCBs, 
hydroxylated PCB metabolites, pesticides and PBDEs), biometric variables, environmental 
(capture location) variables and TH variables were associated with levels of 1,25(OH)2D in 
three groups of adult polar bears; females with cubs of the year (FWCOY), females without 
cubs of the year (FWOCOY) and males. It is hypothesized that there are associations between 
plasma concentrations of POPs and that there are interactions between plasma concentrations 
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of POPs, biometric variables, environmental variables and THs, and 1,25(OH)2D. Thus, the 
aim was to examine effects on 1,25(OH)2D, caused by either single POP compounds, or by 
their combined effects, or by interactions between POPs, biometric and environmental factors 
and THs. 
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2.   Materials and methods 
 
 
 
2.1   Sampling 
 
In April 2008, blood samples were collected from 43 polar bears at Spitsbergen and Edgeøya 
(76.72 – 80.62° N, 12.10 – 23.70° E) at Svalbard, Norway. Blood were sampled from the 
femoral vein of eight females with cubs of the year (FWCOY), 15 females without cubs of 
the year (FWOCOY) and 20 male polar bears. 
 
The polar bears were sedated by the remote injection of a dart (Palmer Cap-Chur Equipment, 
Douglasville, Georgia) filled with Zoletil® (200 mg/mL; Virbac Laboratories, Carros, 
France), fired from a helicopter. The individual amount of drug was determined based on an 
estimation of the bears bodyweight observed from the helicopter (5-10 mg/kg body mass). 
The blood was collected into heparinised Venoject® tubes (10 mL, Thermo Electron 
Corporation, Belgium) and separated into plasma and blood cells by centrifugation (3500 
rpm, 10 min) within 8 h after sampling. Plasma samples were transferred to cryogenic vials 
and stored at – 20 °C in the field and then (after approximately four weeks) at – 70 °C in the 
lab freezer until analysis. Capture and handling procedures followed standard protocols 
(Derocher & Wiig, 2002, Stirling et al., 1989) and were approved by the National Animal 
Research Authority (The National Animal Research Authority (NARA), Oslo, Norway). 
After sedation, a selection of morphometric variabes, representing the bears body size and 
head size were collected. Straight lenght (SL), head lenght (HL), zygomatic width (ZW) and 
axillary girth (AG) were measured in all bears. Body mass (BM) was estimated based on SL 
and AG using a morphometric equation (Derocher & Wiig, 2002) before further recalculation 
into body condition index (BCI) using a BCI equation developed for polar bears (Cattet et al., 
2002). For some of the bears, age was known because they had been caught previously. For 
the remaining ones, age was estimated by counting annual growth layers in the cementum of 
an extracted vestigial premolar (Calvert & Ramsay, 1998, Christensen-Dalsgaard et al., 
2010). 
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Detailed information on sampling coordinates and age for the three groups are listed in Table 
A.1 (Appendix A). 
 
 
2.2   Contaminant analysis 
 
The analysis of organochlorinated and brominated compounds: chlorinated pesticides, 
PCBs, OH-PCBs and PBDEs, were performed at the Laboratory of Environmental 
Toxicology at the Norwegian School of Veterinary Science (Oslo, Norway) using gas 
chromatography-mass spectrophotometry (GC-MS). 
 
The polar bear plasma samples were quantified for the compounds presented in Table 1. The 
method used for extraction, clean up, analyses and information on quality assurance of PCBs 
and OH-PCBs is described by Bytingsvik et al. (2012) based on the method originally 
described by Brevik (1978). It should be noted that 4´OH-CB130 and 4´OH-CB-172 were 
detected in > 60 and 70 % of the individuals, respectively, but they both co-eluted with other 
OH-PCB isomers. Nevertheless, the results on these two compounds were included in the 
analysis. Methods used for extraction, clean up, analyses and quality control of PBDEs and 
chlorinated pesticides are described elsewere (Murvoll et al., 2005, Murvoll et al., 2006, 
Sørmo et al., 2006, Villanger, 2011). Briefly, the extracted samples were analysed for five 
PBDEs (i.e. BDE-47, -153, -154, -183 and -209) using a GC-MS. Limits of detection (LOD) 
for individual compounds were determined as three times the noise level. The detection limit 
for PBDEs were 0.02 ng/g wet weight (w.w). The concentrations of BDE-153, -183 and -209 
were suspected to have high background levels, but results on these were nevertheless 
included in the analysis. Methods used for extraction, clean up, analyses and quality control 
of chlorinated pesticides are described elsewere (Miljeteig et al., 2009). Briefly, the extract 
samples were analysed for eight chlorinated pesticides (i.e. oxychlordane, trans-nonachlor, 
mirex, HCB, α-HCH, β-HCH, p,p,´-DDT and p,p,´-DDE) using a GC-MS. Limit of detection 
for individual compounds were determined as three times the baseline noise level. The 
detection limit for chlorinated pesticides ranged from 0.12-0.68 ng/g w.w. Plasma levels of 
contaminants are expressed as nmol/L. 
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Table 1: The organochlorinated and brominated contaminants and chlorinated pesticides analysed in plasma 
from polar bear (Ursus maritimus) at Svalbard. The abbreviation and IUPAC nomenclature are given. 	  
Organochlorinated and brominated contaminants 
Abbreviation Analyte 
PCB-47 2,2',4,4' - Tetrachlorobiphenyl 
PCB-74 2,4,4',5 - Tetrachlorobiphenyl 
PCB-99 2,2',4,4',5 - Pentachlorobiphenyl 
PCB-101 2,2',4,5,5' - Pentachlorobiphenyl  
PCB-105 2,3,3',4,4' - Pentachlorobiphenyl 
PCB-114 2,3,4,4',5 - Pentachlorobiphenyl 
PCB-118 2,3',4,4',5 - Pentachlorobiphenyl 
PCB-128 2,2',3,3',4,4' - Hexachlorobiphenyl 
PCB-137 2,2',3,4,4',5 - Hexachlorobiphenyl 
PCB-138 2,2',3,4,4',5' - Hexachlorobiphenyl 
PCB-153 2,2',4,4',5,5' - Hexachlorobiphenyl  
PCB-156 2,3,3',4,4',5 - Hexachlorobiphenyl 
PCB-157 2,3,3',4,4',5' - Hexachlorobiphenyl  
PCB-167 2,3',4,4',5,5' - Hexachlorobipheny 
PCB-170 2,2',3,3',4,4',5 - Heptachlorobiphenyl 
PCB-180 2,2',3,4,4',5,5' - Heptachlorobiphenyl     
PCB-183 2,2',3,4,4',5',6 - Heptachlorobiphenyl 
PCB-187 2,2',3,4',5,5',6 - Heptachlorobiphenyl 
PCB-189 2,3,3',4,4',5,5' - Heptachlorobiphenyl 
PCB-194 2,2',3,3',4,4',5,5' - Octachlorobiphenyl 
PCB-206 2,2',3,3',4,4',5,5',6 - Nonachlorobiphenyl 
4-OH-CB107 4-OH-2,3,3´,4´,5 - Pentachlorobiphenyl 
4´OH-CB130 4´-OH-2,2´,3,3´,4´,5 - Hexachlorobiphenyl 
3´OH-CB138 3´-HO-2,2´,3´,4,4´,5 - Hexachlorobiphenyl 
4-OH-CB146 4-OH-2,2´,3,4´5,,5 - Hexachlorobiphenyl 
4´OH-CB159 4-OH-2´,3,3´,4´,5,5 - Hexachlorobiphenyl 
4´OH-CB172 4-OH-2,2´,3,3´,4´,5,5´ - Heptachlorobiphenyl 
3´OH-CB180 3-OH-2,2´,3´,4,4´,5,5´ - Heptachlorobiphenyl 
4-OH-CB187 4-OH-2,2´,3,4,5,5´,6´- Heptachlorobiphenyl 
Oxychlordane oxy-chlordane 
trans-Nonachlor trans-Nonachlor 
Mirex 1,1α,2,2,3,3α,4,5,5,5α,5β,6-dodecachloro-octahydro-1H-1,3,4- 
(methanetriyl)cyclobuta[cd]pentalene 
HCB Hexachlorobenzene 
α-HCH 1α,2α,3β,4α,5β,6β-hexachlorocyclohexane  
β-HCH 1α,2β,3α,4β,5α,6β-hexachlorocyclohexane 
p,p,'-DDT p,p,'-dichloro-α,α-diphenyl-β,β,β-trichloroethane 
p,p,'-DDE o,p,'-dichloro-diphenyl-dichloroethylene 
BDE-47 2,2’,4,4’-Tetrabromodiphenyl ether 
BDE-153 2,2’,4,4’,5,5’-Hexabromobiphenyl ether 
BDE-154 2,2’,4,4’,5,6’-Hexabromobiphenyl ether 
BDE-183 2,2',3',4,4',5',6'-Heptabromodiphenyl ether 
BDE-209 Decabromodiphenyl ether 
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The Laboratory of Environmental Toxicology at The Norwegian School of Veterinary 
Science (Oslo, Norway) is accredited for the determination of several POPs in biological 
material of animal origin according to the requirements of NS-EN ISO/IEC 17025 (TEST 
137). Determination of OH-PCBs is not an accredited method, but is validated after the same 
procedure as the accredited PCB-method. Detailed information on validation and quality 
assurance on POPs are given elsewere (Bytingsvik et al., 2012, Miljeteig et al., 2009, 
Murvoll et al., 2005, Murvoll et al., 2006, Sørmo et al., 2006, Villanger, 2011). 
 
 
2.3   Radioimmunoassay 
 
Radioimmunoassay (RIA) was applied to measure levels of vitamin D (e.g. 1,25(OH)2D)  and 
thyroid hormones (e.g. TT4, free T4 [FT4], TT3 and free T3 [FT3]),  in polar bear plasma. 
The analysis was conducted at Department of Biology, at Norwegian University of Science 
and Technology (NTNU).  
 
The RIA-method is a specific and sensitive method based on the use of antibodies to measure 
concentrations of antigens (e.g. hormonelevels in the blood). This due to competitive binding 
to the antibody by unlabeled (analyte) and radioactive-labeled (tracer) antigens (hormones), 
when there is limited bindingsites available. The unlabelled antigen is the compound to be 
quantified, on the basis of the counts of the tracer-antibody complex, which are inversely 
proportional to the antigen concentration. Based on the counts of bound complexes, a 
standard curve is made. The calibration curve is then used to estimate the concentration of the 
unknown sample (Berson & Yalow, 1968). 
 
 
2.3.1  Vitamin D analysis  
 
Analysis of circulating 1,25(OH)2D were conducted using RIA (Diasorin, Stillwater, MN, 
USA). A gamma-scintillation counter (Cobra Autogamma Counting System, Model 5003; 
Packhard Instrument, Dowers Grove, IL, USA) was used to detect the radioactivity of the 
sample. Samples were analysed as duplicates. The variance between parallels was 3.2 %, and 
the intra-assay variance was 15.5 %. The detection limit was 2.5 pg/ml.  
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2.3.2 TH analysis  
 
Thyroid hormone kits (Coat-A-Count Total T4, Free T4, Total T3 and Free T3, Siemens 
Medical Solutions, Diagnostics, Los Angeles, CA, USA) were used to measure the 
concentrations of total thyroxin (TT4), free thyroxin (FT4), total triiodothyronine (TT3) and 
free triiodothyronine (FT3), in the polar bear plasma (Bertinussen, 2009). The results from 
the analyses in some of the females (ID: 23958, 23781, 23966, 23962, 23703, 23909 and 
23924) are previously reported by Bertinussen (2009).  
 
The analytical methods are described in detail by Bertinussen (2009). The kits consisted of 
antibody coated tubes, tracer (125I labeled thyroxin or triiodothyronine) and calibrators. The 
software for the gammacounter (Spectra Works Spectrum Analysis Software, Meriden, USA) 
calculated a calibration curve based on the calibrator concentrations and the respective count 
numbers. All samples were analysed in duplicates (TT4, TT3 and FT3) and triplicates (FT4). 
The accepted variation between parallels was 15 %. The detection limits were < 1.33 nmol/L 
for TT4, < 0.31 nmol/L for TT3, < 1.29 pmol/L for FT4 and < 0.06 pmol/L for FT3. For 
information on quality assurance, see Bertinussen (2009). 
 
 
2.4   Statistical methods 
 
Simca P12+ (Version 12.0.1, Umetrics, Umeå, Sweden) and SPSS Statistical software 
(Version 20.0 for Mac, IBM, SPSS Inc., Chicago, IL) were used for the multivariate data 
analysis. Other calculations were performed using Microsoft Excel for Mac, 2011. Statistical 
significance was set as p ≤ 0.05.  
 
The data were analysed for normal distribution using the Shapiro-Wilk´s test (n ≤ 50) in 
SPSS 20. Variables not normally distributet were log10 transformed to obtain normality. For 
female polar bears with cubs of the year (FWCOY), this was applied for the following 
variables: latitude, lipid %, condition, head length, zygomatic width, estimated total body 
mass (TBM), body condition index (BCI), oxychlordane, trans-nonachlor, Mirex, HCB, β-
HCH, p,p´-DDE, PCB-47, -74, -99, -101, -137, -138, -156, -156, -157, -170, -180, -183, -187, 
-189, -194 and -206, 4-OH-CB107, 4´OH-CB130, 3´OH-CB138, 4´OH-CB159, 3´OH-
	   	   	  	   	  
	   12	  
CB180, 4-OH-CB187, BDE-154, -183 and -209, 1,25(OH)2D, cholesterol, TT4, FT4, TT3, 
FT3 and FT3:TT3 ratio, Σpesticides and ΣPCBs.  
For females without cubs of the year (FWOCOY), the following variables were log10 
transformed: latitude, longitude, condition, lipid %, trans-nonachlor, p,p´-DDE, p,p´-DDT, 
PCB-74, -101, -105, -114, -167, -170, -180, -183, -194, -206, 4-OH-CB107, 4´OH-CB130, 
3´OH-CB138, 4-OH-CB187, BDE-153, -183 and -209, 1,25(OH)2D, TT4, FT4, FT4:TT4 and 
TT3:TT4.  
For males, the following variables were log10 transformed: latitude, condition, head lenght, 
oxychlordane, trans-nonachlor, α-HCH, β-HCH, p,p´-DDE, p,p´-DDT, PCB-47, -99, -105, -
118, -128, -153, -156, -157, -167, -170, -180, -187, -189, -194, and -206, 4´OH-CB130, 
3´OH-CB138, 4-OH-CB146, 4´OH-CB159, 3´OH-CB180, 4-OH-CB187, BDE-47, -153, -
154, -183 and -209, testosterone, FT4, FT3, FT3:TT3, FT4:TT4, TT3:TT4, Σpesticides, 
ΣPCBs and ΣOH-PCBs.  
 
ANOVA was used to test for between-group differences in contaminant compounds and 
groups, TH, 1,25(OH)2D, cholesterol and lipid content (%). Correlations between 
1,25(OH)2D, THs, POPs and biometric variables were tested using Pearson`s correlation test 
(two-tailed) and Spearman`s rank correlation test (two-tailed), depending on whether the data 
was normally distributed or not, respectively. In the variables analysed, some of the non-
detected values were replaced with random values below the limit of detection (LOD) of the 
chemical. This was applied for the following variables: α-HCH, p,p´-DDT, PCB-74, -101, -
114, -128, -167, TT4 and FT3. 
 
 
2.4.1 Principal component analysis (PCA) 
 
In Simca P12+ (Umetrics, Umeå, Sweden) intercorrelations between variables were 
investigated using principle component analysis (PCA). The main goal was to investigate if 
the plasma 1,25(OH)2D levels in the three groups of polar bears were correlated to biometric 
variables, THs or POP concentrations. In a PCA plot, the included variables are transformed 
to a dataset of uncorrelated variables orthogonally projected on each other, termed principle 
components (PCs), that explains the variance in the dataset. R2 describes the degree of fit in 
the model (explained variance) and Q2 describes the predictive ability of the model (predicted 
variance) (Eriksson et al., 2006). The variables were unit variance (UV) scaled, so that their 
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contribution to the final model is equal, independent of their original values. This is 
important in datasets were the numerical values for variables vary on a great scale. Mean-
centering was also performed on the data to increase the models interpretability (the mean-
value is substracted) (Eriksson et al., 2006). A critical validation of the PCA is essential. This 
is performed with respect to explained variance of each of the PCs and the models goodness 
of prediction. Significant PCs have eigenvalues > 1. Σconcentrations of the contaminant 
groups were not included in the PCA, this to avoid strong covariations. 
 
 
2.4.2 Orthogonal projection to latent structures regression (OPLS) 
 
Orthogonal projections to latent structures (OPLS) regression can be performed when the 
explanatory variables show a high degree of multicolinearity, such as in the present dataset, 
by using Simca P12+. OPLS is a statistical tool designed to perform multiple regression 
when somehow the number of observations are limited and when there is a high degree of 
colinearity. 
 
The OPLS method can assess the relationship (positive or negative) between 1,25(OH)2D and 
the most important predictor variables, and may thus identify combined effects of different 
POP compounds and biometric, environmental and TH variables on 1,25(OH)2D. Therefore, 
the OPLS complements the statistical series and may detect relationships when several 
explanatory variables affect the models, which is not displayed by PCA or a bivariate test. 
The indications from the PCA and correlation test were used to optimize the OPLS model. 
This, by removing some of the variables of low importance, i.e., with small regression 
coefficients and low VIP values, to see if significant OPLS regression models could be 
obtained for 1,25(OH)2D (Wold et al., 2001). 
 
The OPLS and PLS is a better tool than multiple regression when handling data with a high 
degree of colinearity and noise in X and Y matrix, according to Trygg and Wold (2002). The 
OPLS differs from its precursor PLS, in that an OPLS separates the variation in predictor 
variable X into variation which is correlating and non-correlating (orthogonal[90°]) with the 
variation in response variable Y. An OPLS is critical validated with respect to R2X (explained 
variance) and R2Y (goodness of fit), and a high goodness of prediction (Q2) is essential. R2Y 
> 0.7 and a Q2 > 0.4 denote highly significant models when analyzing biological data 
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(Lundstedt et al., 1998). “Variable importance in projection” (VIP) plots denote the 
importance of each X variable in the predicted model and rank them in their explanatory 
power of Y. Combined with coefficient plots with jack-knifed confidence intervals, one can 
identify both the important and significant model predictors. VIP values > 1 is the most 
relevant variables explaining the Y. An “Analysis of variance of the cross-validated residuals” 
(CV-ANOVA) tests the significance of the OPLS regression. 
 
A multiple linear regression was performed between 1,25(OH)2D and some of the most 
correlated variables. This was performed in the default enter method in SPSS to examine the 
possible multicolinearity. The aim for the OPLS and multiple regressions was to investigate 
the combined effects from POPs, biometric, environmental and TH variables on 1,25(OH)2D. 
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3. Results 
 
 
3.1   Biometric variables 
 
Information on capture locations, estimated age (years) and biometric variables of the polar 
bears are presented in Table 2 below. The individuals ranged in ages from 4 to 21 years, wich 
defines them all as being adults. Individual biometric measurements are presented in Table 
B.1 (Appendix B). 
 
Table 2: Capture location, age and biometric variables in female polar bears (Ursus maritimus) with cubs of the 
year (FWCOY, n=8), females without cubs of the year (FWOCOY, n=15) and males (n=20), sampled in 
Svalbard (Norway) in 2008. Variables are presented as mean (X) ± standard deviation (SD), median and range 
(min – max). 
 
  X  ±  SD Median Min - Max nc 
FWCOY      Latitude (°)       78.4 ± 0.9 78.4   77.1 – 79.5 8 
Longitude (°)   17.9 ± 2.6 17.8   13.9 – 21.9 8 
Age (years) 10.12 ± 3.8 11        5 – 15 8 
Condition (1=poor, 5=good)     2 ± 0 2        2 – 2 8 
Straight length (cm) 194 ± 7 193    183 – 205 8 
Axillary girth (cm)   113 ± 12 112      99 – 136 8 
Head length (mm)  342 ± 8 344    329 – 351 8 
Zygomatic width (mm)  198 ± 5 199    186 – 203 8 
Estimated total body mass (kg)a    180 ± 37 174    139 – 260 8 
Body Condition Indexb    155 ± 14 154    138 – 184 8 
          
FWOCOY         
Latitude (°)    78.6 ± 1.1 79.0   76.7 – 79.8 15 
Longitude (°)    16.5 ± 3.7 16.1   12.1 – 22.3 15 
Age (years)      9 ± 3 8        6 – 16 15 
Condition (1=poor, 5=good)      3 ± 1 3        2 – 4 15 
Straight length (cm)  195 ± 7 195    181 – 205 15 
Axillary girth (mm)  112 ± 7 110    101 – 127 15 
Head length (mm)    346 ± 10 345    331 – 366 15 
Zygomatic width (mm)    200 ± 10 199    183 – 216 15 
Estimated total body mass (kg)a    181 ± 26 170    134 – 237 15 
Body Condition Indexb    156 ± 11 152    135 – 177 15 
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Table 2. Continued 
 
  X  ±  SD Median Min - Max nc 
Males         
Latitude (°)    78.9 ± 1.1 79.2 76.7 – 80.6 20 
Longitude (°)    17.6 ± 3.1 18.1 12.6 – 23.7 20 
Age (years)    13 ± 3 13   4 – 20 20 
Condition (1=poor, 5=good)      3 ± 1 3 2 – 4 20 
Straight length (cm)    232 ± 11 231 214 – 252 20 
Axillary girth (cm)    152 ± 14 154 127 – 176 20 
Head length (mm)    400 ± 18 402 358 – 439 20 
Zygomatic width (mm)    255 ± 20 258 215 – 288 20 
Estimated total body mass (kg)a    390 ± 81 396 255 – 539 20 
Body Condition Indexb    213 ± 16 215 183 – 239 20 
 
a Estimated total body mass (BM) of the polar bears is based on the following equation: BM = 0.00003377 * 
axillary girth1.7515 * straight length1.3678 (Derocher & Wiig, 2002). 
b Body Condition Index (BCI) of the polar bears were estimated based on the following equation: BCI = (ln 
body mass – 3.07 * ln straight length + 10.76)/(0.17 + 0.009 * ln straight length= (Cattet et al., 2002). ln = 
natural logarithm. 
c Number of observations 
 
 
 
3.2   Vitamin D and  thyroid hormone levels  
 
The serum levels of 1,25(OH)2D, thyroid hormones, cholesterol and lipid content in the three 
groups are presented in Table 3 (FWCOY), Table 4 (FWOCOY) and Table 5 (males).  
 
There were no significant difference in the 1,25(OH)2D levels between the three groups 
(Table 6: ANOVA; p > 0.05). The average 1,25(OH)2D levels found in the current study was 
0.81 nmol/L in FWCOY, 0.68 nmol/L in FWOCOY and 0.56 nmol/L in males, with a 
standard deviation of 0.43 nmol/L, 0.16 nmol/L and 0.23 nmol/L, respectively (Table 3, 4 
and 5). Individual levels of serum 1,25(OH)2D are presented in Table C.1 (Appendix C). 
 
For thyroid hormones, levels of T4 dominated over levels of T3 in all individuals, both for 
the bound and free fractions (Table 3, 4 and 5). Individual thyroid hormone levels are 
presented in Table D.1 (Appendix D).  
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Table 3: Lipid content (%), cholesterol levels (mmol/L), levels of 1,25(OH)2D (nmol/L), total (nmol/L) and free 
(pmol/L) T3 and T4, and FT3:TT3, FT4:TT4, TT3:TT4 with mean (X) ± standard deviation (SD), median, 
range (min – max) and number of individuals with detectable levels (n) in plasma/serum samples of female 
polar bears with cubs of the year (FWCOY)  from Svalbard (Norway), sampled in 2008. 	  
  FWCOY (n=8)  
   X ± SD Median Min - Max   ne 
Lipid        1.30 ± 0.23 1.21  1.0 – 1.59 8 
Cholesterol 9.24 ± 1.98 9.25   5.4 – 11.5 8 
1,25(OH)2D 0.81 ± 0.43 0.61 0.33 – 1.52 8 
THs 	   	  	   	   8 
TT4a  18.6 ± 6.16 18.1 11.3 – 31.2 8 
FT4b  7.04 ± 2.21 6.56 5.02 – 11.3 8 
TT3c  1.10 ± 0.19 1.17 0.69 – 1.27 8 
FT3d  0.40 ± 0.24 0.52 0.06 – 0.65 7 
FT3:TT3 0.03 ± 0.02 0.04 0.01 – 0.06 8 
FT4:TT4 0.03 ± 0.01 0.04 0.03 – 0.05 8 
TT3:TT4 0.06 ± 0.01 0.06 0.03 – 0.10 8 
 
a total thyroxine 
b free thyroxine 
c total triiodothyronine 
d free triiodothyronine 
e Number of samples with detectable concentrations. 
 
 
Table 4: Lipid content (%), cholesterol levels (mmol/L), levels of 1,25(OH)2D (nmol/L), total (nmol/L) and free 
(pmol/L) T3 and T4, and FT3:TT3, FT4:TT4, TT3:TT4 with mean (X) ± standard deviation (SD), median, 
range (min – max) and number of individuals with detectable levels (n) in plasma/serum samples of female 
polar bears without cubs of the year (FWOCOY) from Svalbard (Norway), sampled in 2008. 	  
  FWOCOY (n=15)  
  X ± SD Median Min - Max  nc 
Lipid  1.34 ± 0.21 1.36 0.82 – 1.56 15 
Cholesterol 9.02 ± 1.61 9.1   5.7 – 13.1 15 
1,25(OH)2D 0.68 ± 0.16 0.65 0.41 – 1.05 15 
THs 	   	   	   15 
TT4a  16.7 ± 7.74 15.5 7.78 – 37.8 15 
FT4b  7.84 ± 2.99 7.23 3.51 – 14.8 15 
TT3c  1.28 ± 0.24 1.3 0.79 – 1.62 15 
FT3d  0.60 ± 0.31 0.5 0.24 – 1.49 15 
FT3:TT3 0.04 ± 0.01 0.04 0.03 – 0.09 15 
FT4:TT4 0.04 ± 0.01 0.05 0.04 – 0.08 15 
TT3:TT4 0.08 ± 0.03 0.08 0.04 – 0.18 15 
 
a total thyroxine 
b free thyroxine 
c total triiodothyronine 
d free triiodothyronine 
e Number of samples with detectable concentrations. 
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Table 5: Lipid content (%), cholesterol levels (mmol/L), levels of 1,25(OH)2D (nmol/L), total (nmol/L) and free 
(pmol/L) T3 and T4, and FT3:TT3, FT4:TT4, TT3:TT4 with mean (X) ± standard deviation (SD), median, 
range (min – max) and number of individuals with detectable levels (n) in plasma/serum samples of male polar 
bears from Svalbard (Norway), sampled in 2008. 	  
  Males (n=20)   
  X ± SD Median Min - Max ne 
Lipid  0.82 ± 0.17 0.79 0.56 – 1.22 20 
Cholesterol 6.29 ± 1.19 6.25   3.9 – 8.30 20 
1,25(OH)2D 0.56 ± 0.23 0.59 0.19 – 1.03 20 
THs 	   	   	   20 
TT4a  9.19 ± 4.39 8.31 1.33 – 18.9 20 
FT4b  4.63 ± 1.67 4.38 1.51 – 8.58 20 
TT3c  0.83 ± 0.21 0.77 0.52 – 1.34 20 
FT3d  0.21 ± 0.18 0.17     0.06 – 0.7 20 
FT3:TT3 0.02 ± 0.01 0.02 0.01 – 0.05 20 
FT4:TT4 0.05 ± 0.02 0.05 0.03 – 0.11 20 
TT3:TT4 0.11 ± 0.09 0.09 0.06 – 0.51 20 
 
a total thyroxine 
b free thyroxine 
c total triiodothyronine 
d free triiodothyronine 
e Number of samples with detectable concentrations. 
 
 
In the present study, plasma concentrations of TT4 and FT4 in males were significantly lower 
than in FWCOY and in FWOCOY (ANOVA; TT4: df = 2, F = 9.93, p < 0.001; FT4: df = 2, 
F = 8.9, p = 0.001). TT3 and FT3 levels were significantly lower in males compared to levels 
in FWCOY (TT3: ft = 2, F = 17.59, p < 0.001; FT3: ft = 2, F = 10.72, p < 0.001), but did not 
differ significantly from levels in FWOCOY. FT3:TT3 levels were significantly higher in 
FWOCOY compared to levels in males (FT3:TT3: ft = 2, F = 8.26, p = 0.001), but did not 
differ significantly from levels in FWCOY. Levels of FT4:TT4 were significantly higher in 
males compared to FWCOY (ft = 2, F = 3.74, p = 0.032), but not in comparison to levels in 
FWOCOY. There were no significant differences in TT3:TT4 levels between the three 
groups. Furthermore, there were no difference in any of the TH variables between FWCOY 
and FWOCOY (Table 6). Levels of cholesterol, and lipid content were significantly lower in 
males, in comparison with levels in females. 
For more information on group differenses, see Table E.1 (Appendix E). 
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Table 6. Statistical differences between levels of 1,25(OH)2D (nmol/L), cholesterol (mmol/L), lipid content 
(%), and total (nmol/L) and free (pmol/L) T4 and T3 in plasma of polar bears (FWCOY, FWOCOY and males) 
sampled in Svalbard (Norway) in 2008, given as F-statistics and significance level (p) from analysis of variance. 
For significant differences p-values are given in bold. 	  
 
  ANOVA 
  F p 
1,25(OH)2D  2.76 0.076 
Cholesterol  18.53 < 0.001 
Lipid (%) 35.44 < 0.001 
THs     
TT4a 9.93 < 0.001 
FT4b 8.90 0,001 
TT3c 17.59 < 0.001 
FT3d 10.72 < 0.001 
FT3:TT3 8.26 < 0.001 
FT4:TT4 3.74 0.032 
TT3:TT4 1.83 0.173 
 
a total thyroxine 
b free thyroxine 
c total triiodothyronine 
d free triiodothyronine 
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3.3   Prevalence and levels of contaminants 
 
The results of analysis are given in Table 7 (PCBs, OH-PCBs), Table 8 (chlorinated 
pesticides) and Table 9 (PBDEs). Forty-two contaminants were analysed, and PCBs and 
chlorinated pesticides were quantified in 100 % of the individuals. OH-PCBs and PBDEs 
were quantified in 60 % or more, of the individuals in the three groups of polar bears. 4'-OH-
CB130 were not detected in 3 (37.5 %) of FWCOY, and was only detected in 12 (60 %) of 
the male individuals. For the PBDEs, BDE-47 and BDE-153 were detected in 7 (87.5 %) and 
6 (75 %) of FWCOY, respectively. BDE-153 was detected in 14 (93.3 %) of the  FWOCOY. 
For males, BDE-153, BDE-183 and BDE-209 were all detected in 19 (95 %) of the male 
individuals. The contaminant group that were present in the highest concentration in the 
plasma samples of female and male polar bears were, in decreasing order, Σ8OH-PCBs > 
Σ21PCBs > Σ8pesticides > Σ5PBDEs. Σ8OH-PCBs was almost 2 times higher than Σ21PCBs, 
and amost 7 times higher than Σ8pesticides (FWCOY and FWOCOY), while Σ8OH-PCBs 
was 17 times higher than Σ8pesticides in males. The most prevalent congener of Σ8OH-PCBs 
in plasma of all three polar bear groups were 4-OH-CB187, which constituted 49.6 %, 49.3 
%, and 35.0 % of the total Σ8OH-PCBs in FWOCOY, FWCOY and males, respectively. The 
Σ21PCBs was the second largest contaminant group, of which PCB-153 was the most 
prevalent congener, constituting 39.0 %, 38.8 %, and 37.0 % of the Σ21PCBs in FWCOY, 
FWOCOY and males, respectively. The plasma concentrations of pesticides and PBDEs (i.e 
Σ8pesticides, Σ5PBDEs) were low as compared to the concentrations of Σ8OH-PCBs and 
Σ21PCBs,  and contributed in sum with < 1.6 % of the total contaminant burden, for all three 
polar bear groups. 
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Table 7.  Concentrations of PCBs and OH-PCB (nmol/L), with mean (X),  standard deviation (SD) and number 
of individuals with detectable levels (n) in plasma samples of polar bears (FWCOY, FWOCOY and males) from 
Svalbard (Norway), sampled in 2008. 
 
  FWCOY   FWOCOY   Males 
  (n = 8)   (n = 15)   (n = 20) 
  X ± SD nd   X ± SD nd   X ± SD nd 
PCB-47 0.53 ± 0.46 8   0.55 ± 0.34 15   0.54 ± 0.48 20 
PCB-74a 0.38 ± 0.14 8   0.33 ± 0.08 14   0.31 ± 0.12 17 
PCB-99 12.0 ± 12.5 8   11.7 ± 7.20 15   7.93 ± 5.31 20 
PCB-101a 0.22 ± 0.24 4   0.21 ± 0.11 12   0.17 ± 0.11 11 
PCB-105 0.24 ± 0.15 8   0.20± 0.10 15   1.00 ± 3.10 20 
PCB-114a 0.07 ± 0.03 6   0.07 ± 0.04 15   0.06 ± 0.01 20 
PCB-118 1.23 ± 0.66 8   1.19 ± 0.42 15   1.30 ± 0.69 20 
PCB-128a 0.13 ± 0.11 7   0.14 ± 0.10 11   0.12 ± 0.09 12 
PCB-137 1.15 ± 1.16 8   1.13 ± 0.67 15   0.68 ± 0.42 20 
PCB-138 9.66 ± 10.1 8   10.7 ± 6.79 15   8.35 ± 5.79 20 
PCB-153 60.4 ± 68.7 8   58.2 ± 36.4 15   48.3 ± 36.1 20 
PCB-156 2.56 ± 2.80 8   2.21 ± 1.48 15   2.09 ± 1.27 20 
PCB-157 1.66 ± 1.94 8   1.57 ± 1.41 15   2.11 ± 1.18 20 
PCB-167a 0.06 ± 0.03 2   0.05 ± 0.04 5   0.04 ± 0.04 9 
PCB-170 14.7 ± 16.3 8   15.0 ± 12.3 15   17.0 ± 12.9 20 
PCB-180 36.8 ± 43.5 8   35.0 ± 21.1 15   28.7 ± 21.8 20 
PCB-183 0.99 ± 1.13 8   1.00 ± 0.59 15   0.57 ± 0.40 20 
PCB-187 0.19 ± 0.14 8   0.22 ± 0.11 15   0.14 ± 0.10 20 
PCB-189 0.39 ± 0.37 8   0.38 ± 0.25 15   0.55 ± 0.37 20 
PCB-194 9.74 ± 7.99 8   8.45 ± 3.98 15   9.22 ± 5.51 20 
PCB-206 1.70 ± 1.12 8   1.51 ± 0.59 15   1.36 ± 0.73 20 
4-OH-CB107 15.8 ± 13.6 8   9.41 ± 4.97 12   13.4 ± 8.39 19 
4'-OH-CB130 0.51 ± 0.53 5   0.42 ± 0.18 12   0.51 ± 0.27 12 
3'-OH-CB138 1.71 ± 1.19 8   2.11 ± 1.08 12   3.24 ± 2.13 19 
4-OH-CB146 75.4 ± 41.9 8   66.1 ± 20.2 12   31.1 ± 21.7 19 
4'-OH-CB159 2.00 ± 2.63 8   0.59 ± 0.28 12   0.66 ± 0.33 19 
4'-OH-CB172 43.9 ± 31.5 8   46.9 ± 14.3 12   60.3 ± 19.8 19 
3'-OH-CB180 2.43 ± 1.00 8   2.34 ± 1.02 12   5.58 ± 3.22 19 
4-OH-CB187 137 ± 88.2 8   126 ± 52.0 12   78.5 ± 62.2 19 
Σ21PCBsb 155 ± 167     150 ± 91.2     131 ± 88.7   
Σ8OH-PCBsc 279 ± 151     254 ± 82.4     225 ± 104   
 
a Missing values were given a random number between zero and limit of detection (LOD) and included in the 
following statistics. 
b Σ21PCBs include PCB-47, -74, -99, -101, -105, -114, -118, -128, -137, -138, -153, -156, -157, -167, -170, -180, 
-183, -187, -189, -194 and -206. 
c Σ8OH-PCBs include 4-OH-CB107, 4'-OH-CB130, 3'-OH-CB138, 4-OH-CB146, 4'-OH-CB159, 4'-OH-CB172, 
3'-OH-CB180, 4-OH-CB187. 
d Number of samples with detectable concentrations. 
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Table 8.  Concentrations of chlorinated pesticides (nmol/L), with mean (X), standard deviation (SD) and 
number of individuals with detectable levels (n) in plasma samples of polar bears (FWCOY, FWOCOY and 
males) from Svalbard (Norway), sampled in 2008. 
 
  FWCOY   FWOCOY   Males   
  (n = 8)   (n = 15)   (n = 20)   
  X ± SD nc   X ± SD nc   X ± SD nc   
HCB 3.23 ± 2.62 8   3.56 ± 3.00 15   5.57 ± 4.77 20   
α-HCHa 0.08 ± 0.04 6   0.12 ± 0.04 14   0.07 ± 0.02 17   
β-HCH 0.72 ± 0.42 8   0.81 ± 0.46 15   1.07 ± 0.70 20   
Oxychlordane 34.4 ± 35.7 8   30.4 ± 20.8 15   3.89 ± 2.65 20   
Trans-nonachlor 1.23 ± 0.96 8   1.49 ± 0.99 15   1.08 ± 0.77 20   
Mirex 0.23 ± 0.14 8   0.18 ± 0.07 15   0.13 ± 0.04 20   
p,p'-DDE 1.05 ± 2.01 8   0.81 ± 0.43 15   0.80 ± 0.67 20   
p,p'-DDTa 0.32 ± 0.31 4   0.32 ± 0.44 8   0.30 ± 0.48 7   
Σ8 pesticidesb                   
 
a Pesticides with missing values were given a random number between zero and limit of detection (LOD) and 
included in the following statistics. 
b Σ8 pesticides include HCB, α-HCH, β-HCH, oxychlordane, trans-nonachlor, mirex, p,p'-DDE and p,p'-DDT. 
c Number of samples with detectable concentrations. 
 
 
 
 
Table 9. Concentrations of polybrominated diphenyl ethers (PBDEs) (nmol/L), with mean (X), standard 
deviation (SD) and number of individuals with detectable levels (n) in plasma samples of polar bears (FWCOY, 
FWOCOY and males) from Svalbard (Norway), sampled in 2008. 
 
  FWCOY   FWOCOY   Males 
  (n = 8)   (n = 15)   (n = 20) 
  Mean ± SD nc   Mean ± SD nc   Mean ± SD nc 
BDE-47 0.49 ± 0.31 7 
 
0.43 ± 0.25 15 
 
0.18 ± 0.12 20 
BDE-153a 0.11 ± 0.05 6  0.13 ± 0.06 14  0.10 ± 0.04 19 
BDE-154 0.23 ± 0.23 8   0.21 ± 0.13 15   0.17 ± 0.12 20 
BDE-183 0.16 ± 0.19 8   0.40 ± 0.37 15   0.30 ± 0.27 19 
BDE-209a 0.04 ± 0.01 8   0.04 ± 0.03 15   0.06 ± 0.05 19 
Σ5PBDEsb 	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
 
a Detected concentrations are close to the detection limit. 
b Σ5PBDEs include BDE-47, BDE-153, BDE-154, BDE-183 and BDE-209.  
c Number of samples with detectable concentrations. 
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Plasma concentrations of oxychlordane, 4-OH-CB146 and BDE-47 in males were 
significantly lower than in FWCOY and FWOCOY (ANOVA; oxychlordane: df = 2, F = 
53.84, p < 0.001; 4-OH-CB146: df = 2, F = 11.37, p < 0.001; BDE-47: ft = 2, F = 11.07, p < 
0.001). PCB-183 levels were significantly lower in males, compared to FWOCOY (ft = 2, F 
= 3.48, p = 0.041) but did not differ significantly in comparison to levels in FWCOY. Levels 
of 4'-OH-CB159 and mirex were significantly lower in males compared to FWCOY (4'-OH-
CB159: ft = 2, F = 5.03, p = 0.012; mirex: ft = 2, F = 3.74, p = 0.032) but were not 
significantly lower compared to levels in FWOCOY. Levels of 3'-OH-CB138 were 
significantly higher in males compared to FWCOY (ft = 2, F = 4.72, p = 0.015), but did not 
differ significantly from levels in FWOCOY. There were no significant differences in the 
other compound levels between the three groups (Table 10). 
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Table 10. Statistical differences between levels of PCBs (nmol/L), OH-PCBs (nmol/L), pesticides (nmol/L), 
PBDEs (nmol/L), Σ21PCBs, Σ8OH-PCBs, Σ8pesticides and Σ5PBDEs in plasma of polar bears (FWCOY, 
FWOCOY and males) sampled in Svalbard (Norway) in 2008, given as F-statistics and significance level (p) 
from analysis of variance. For significant correlations p-values are given in bold. 
 
    ANOVA 
  
 
F p 
PCB-47   0.32 0.726 
PCB-74   0.89 0.417 
PCB-99   2.01 0.148 
PCB-101a   0.90 0.413 
PCB-105   2.88 0.068 
PCB-114a   0.62 0.542 
PCB-118   0.25 0.782 
PCB-128a   0.31 0.738 
PCB-137   2.91 0.066 
PCB-138   0.96 0.392 
PCB-153   0.70 0.503 
PCB-156   0.03 0.973 
PCB-157   2.56 0.090 
PCB-167a   1.26 0.295 
PCB-170   0.66 0.521 
PCB-180   0.67 0.516 
PCB-183   3.48 0.041 
PCB-187   2.53 0.093 
PCB-189   1.74 0.189 
PCB-194   0.04 0.958 
PCB-206   0.32 0.731 
4-OH-CB107   0.93 0.403 
4'-OH-CB130   0.27 0.764 
3'-OH-CB138   4.72 0.015 
4-OH-CB146   11.4 < 0.001 
4'-OH-CB159   5.03 0.012 
4'-OH-CB172   2.95 0.065 
3'-OH-CB180   13.2 < 0.001 
4-OH-CB187   3.57 0.038 
HCB   1.31 0.281 
α-HCHa   1.51 0.233 
β-HCH   1.72 0.193 
Oxychlordane   53.8 < 0.001 
Trans-nonachlor 0.69 0.509 
Mirex   3.74 0.032 
p,p'-DDE   1.03 0.367 
p,p'-DDT   0.09 0.912 
BDE-47   11.1 < 0.001 
BDE-153b   1.28 0.291 
BDE-154   0.71 0.497 
BDE-183   1.78 0.181 
BDE-209b   1.48 0.240 
Σ21PCBs       
Σ8OH-PCBs       
Σ8pesticides       
Σ5PBDEs       
a Missing values were given a random number between zero and limit of detection (LOD) and included in the 
following statistics. 
b Detected concentrations are close to the detection limit.
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3.4   Relationships between vitamin D levels, biometric 
        variables, THs and POPs 
 
 
 
 3.4.1 Females with cubs of the year, FWCOY 
 
 
 
Principal component analysis 
 
The analysis resulted in a PCA model (Figure 2) with 2 significant principal components. 
PC1 and PC2 explained 49.1 and 15.5 % of the variation, respectively (R2X = 0.647, Q2 = 
0.144). Since all observations were within the Hotellings T2 range, no outliers were present. 
The loadings of PCA indicated that several of the contaminants were clustered together along 
PC1 (PC1 = 0.145 – 0.185), and were distinctly separated from 1,25(OH)2D. The plasma 
levels of 1,25(OH)2D were positively associated with thyroid hormones (FT3, FT3:TT3, TT4, 
FT4), longitude and age. In addition, 1,25(OH)2D was negatively associated with HCB, 
BDE-153, PCB-128, straight length, 4-OH-CB187 and lipid%. FT4:TT4 was oriented 
towards the center of the plot, indicating that it was less important to the model. TT3:TT4 
were located along PC2 and thus negatively associated with p,p´-DDE. The levels of TT3 
was oriented along PC1 and thus negatively associated with several PCBs (PCB-167, -187, -
194 and -206), BDE-47, β-HCH and mirex. 	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Figure 2: PCA loading plot of the relationships among the observations and the variables in female polar bears 
(Ursus maritimus) with cubs of the year (FWCOY) (n = 8), from Svalbard. A total of 62 variables were included 
in the model; latitude, longitude, age, condition, straight length, axillary girth, head length, zygomatic width,  
total body mass, body condition index, lipid content, cholesterol, 8 pesticides, 21 PCBs, 8 OH-PCBs, 5 PBDEs, 
THs and 1,25(OH)2D. 
 
 
Orthogonal Projections to Latent Structures (OPLS) 
  
To explore further the relations observed from the PCA-model, a single Y OPLS-model was 
applied to investigate the relationships between predictor variables (THs, contaminants, 
biological and environmental factors) and 1,25(OH)2D (Y) (Figure 3). Stepwise removal of 
the variables of least importance resulted in a significant model (Wold et al., 2001). The 
OPLS model predicted that the variation in 1,25(OH)2D was significantly explained by 12 
variables (R2X = 0.55, R2Y = 0.84 and Q2 = 0.73, CV-ANOVA; p = 0.042). In PLS models, 
R2Y > 0.7 and a Q2 > 0.4 denote highly significant models when analyzing biological data 
(Lundstedt et al., 1998). The highest VIP (variable importance in projection) value was 
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shown by BDE-153, followed by FT3, age, FT3:TT3 ratio, FT4 and HCB (VIP > 1). Hence, 
these variables were considered to be the most important for explaining the variation in 
1,25(OH)2D. The information from the variable importance plot (VIP) (Figure 3) is 
complemented with a coefficient plot (Figure 4). These two plots summarize the overall 
contribution from each X variable, indicating which are correlated with Y (1,25(OH)2D), and 
identifies if the direction of the relationship (between Y and the X variables) is positive or 
negative. The coefficient plot showed that FT3, age, FT3:TT3 ratio and FT4 were positively 
correlated to 1,25(OH)2D. In contrast BDE-153 and HCB were inversely associated with 
1,25(OH)2D levels in FWCOY (Figure 4). Further testing, using bivariate correlations, 
confirmed that FT3 (p = 0.004, rs = 0.879, n = 8), age (p = 0.018, rp = 0.797, n = 8), FT3:TT3 
(p = 0.022, rs = 0.783, n = 8), FT4 (p = 0.048, rs = 0.711, n = 8), and also zygomatic width (p 
= 0.000, rs = 0.945, n = 8) and TT4 (p = 0.036, rp = 0.739, n = 8) were positively correlated 
with 1,25(OH)2D levels. In contrast, BDE-153 (p = 0.005, rp = -0.941, n = 6) and HCB (p = 
0.033, rs = -0.747, n = 8) were inversely correlated with 1,25(OH)2D levels in FWCOY. It 
should, however, be noted that the BDE-153 concentrations were suspected to have high 
background levels (see discussion). The PCA plot (Figure 2) indicated negative relationships 
between PCBs and 1,25(OH)2D. However, further correlation tests showed that none of the 
PCBs correlated with 1,25(OH)2D.  
 
The linear relationships between 1,25(OH)2D, FT3 and age are presented graphically in 
Figure 5.  
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Figure 3: Orthogonal projections to latent structures (OPLS) regression VIP plot with important variables for 
the explanation of 1,25(OH)2D levels in female polar bears (Ursus maritimus) with cubs of the year (FWCOY) 
(n = 8), from Svalbard. Variables with VIP > 1 are of high importance in the model. All variables are shown 
with default jack-knife confidence intervals, where larger intervals that cross the 0 line represent the lower 
reliability. For identification of abbreviations, see Table 1 (POPs) and Table 3 (THs). 
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Figure 4: Orthogonal projections to latent structures (OPLS) regression coefficient plot summarizing the 
relationship between the contaminant levels, TH levels, biological and environmental factors (X-variables) on 
plasma/serum 1,25(OH)2D levels (Y-variable) in female polar bears (Ursus maritimus) with cubs of the year 
(FWCOY) (n = 8), from Svalbard. Negative coefficients represent inverse relationships and positive coefficients 
represent positive relationships of the X-variables with 1,25(OH)2D levels. Variables with the highest absolute 
coefficient values are considered to be most important in explaining the Y-variable 1,25(OH)2D. Jack-knife 
confidence intervals that cross the 0 line indicate that the predictor is of low importance to the model. For 
identification of abbreviations, see Table 1 (POPs) and Table 3 (THs). 
 
 
 
 
 
 
 
 
	   	   	  	   	  
	   30	  
 
 
 
 
 
 
 
 
 
 
A)         B)      
 
 
Figure 5: The linear relationship (± 95% confidence interval) between 1,25(OH)2D serum concentrations 
(nmol/L) and A) FT3 (pmol/L) and B) Age in female polar bears (Ursus maritimus) with cubs of the year 
(FWCOY) (n = 8), from Svalbard, sampled in 2008. The Pearson correlation, p, and r-values are shown in the 
plot. 
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3.4.2 Females without cubs of the year, FWOCOY 
 
 
Principal Component Analysis 
 
The analysis resulted in a PCA model (Figure 6) with 3 significant principal components. 
PC1 and PC2 explained 35.1 and 14.7 % of the variation, respectively (R2X = 0.618, Q2 = 
0.052). PC3 explained 1.2 % of the variation. Since all observations were within the 
Hotellings T2 range, no outliers were present. The loadings of PCA indicated that several of 
the contaminants were clustered together along PC1 (PC1 = 0.180 – 0.205), and thus, seemed 
to be associated to the plasma levels of 1,25(OH)2D. 1,25(OH)2D grouped closely together 
with PCB-128, 4-OH-CB187 and 4´OH-CB159, thus indicated a positive relationship 
between these. In addition, 1,25(OH)2D was negatively associated with BDE-209 and 
zygomatic width. FT4, TT3 and TT4 were oriented towards the center of the plot, indicating 
that these were less important to the model. TT3:TT4 was located along PC1 and thus 
negatively associated with p,p´-DDE. The levels of FT3, FT4:TT4 and FT3:TT3 were 
clustered together along PC2 and thus negatively associated with PCB-74, BDE-153 and α-
HCH. 
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Figure 6: : PCA loading plot of the relationships among the observations and the variables in female polar bears 
(Ursus maritimus) without cubs of the year (FWOCOY) (n = 15), from Svalbard. A total of 62 variables were 
included in the model; latitude, longitude, age, condition, straight length, axillary girth, head length, zygomatic 
width,  total body mass, body condition index, lipid content (%), cholesterol, 8 pesticides, 21 PCBs, 8 OH-
PCBs, 5 PBDEs, THs and 1,25(OH)2D. 
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Orthogonal Projections to Latent Structures (OPLS)  
 
To explore further the relations observed from the PCA-model, a single Y OPLS-model was 
applied to investigate the relationships between predictor variables (THs, contaminants, 
biological and environmental factors) and 1,25(OH)2D (Y) (Figure 7). Stepwise removal of 
the variables of least importance resulted in a significant model (Wold et al., 2001). The 
OPLS model predicted that the variation in 1,25(OH)2D was significantly explained by 25 
variables (R2X = 0.43, R2Y = 0.64 and Q2 = 0.55, CV-ANOVA; p = 0.013). The highest VIP 
(variable importance in projection) values were shown by 4´OH-CB187, followed by 4´OH-
CB172, 4-OH-CB146, 3´OH-CB180, BDE-47, 3´OH-CB138, BDE-209, BDE-154 and PCB-
105 (VIP > 1). Hence, these variables were considered to be the most important for 
explaining the variation in 1,25(OH)2D. The coefficient plot showed that 4´OH-CB187, 
4´OH-CB172, 4-OH-CB146, 3´OH-CB180, BDE-47, 3´OH-CB138, BDE-154 and PCB-105 
were positively correlated to 1,25(OH)2D. In contrast BDE-209 was inversely associated with 
1,25(OH)2D levels in FWOCOY (Figure 8). It should be noted that the validation parameter 
R2X was below the value that defines a good model using biological data; R2X > 0.7. 
However, the criteria of predictability were met; Q2 > 0.4 (Lundstedt et al., 1998). 
 
Further testing, using bivariate correlations, confirmed that 4-OH-CB187 (p = 0,049, rs = 
0.578, n = 12), 4´OH-CB172 (p = 0.048, rp = 0.580, n = 12), BDE-47 (p = 0.012, rp = 0.631, n 
= 15), 3´OH-CB138 (p = 0.047, rs = 0.582, n = 12), BDE-154 (p = 0.021, rp = 0.590, n = 15), 
and also PCB-47 (p = 0.025, rp = 0.575, n = 15), PCB-128 (p = 0.034, rp = 0.549, n = 15), 
oxychlordane (p = 0.040, rp = 0.534, n = 15), p,p´DDE (p = 0.028, rs = 0.567, n = 15) and 
PCB-189 (p = 0.041, rp = 0.532, n = 15) were positively correlated with 1,25(OH)2D levels. 
In contrast, BDE-209 (p = 0.013, rs = -0.623, n = 15) was inversely correlated with 
1,25(OH)2D levels in FWOCOY. It should be noted that 4´OH-CB172 co-eluted with another 
OH-PCB isomer, and that BDE-209 concentrations were suspected to have high background 
levels. Hence, these results should be considered as semi-quantitative. 
 
The linear relationships between 1,25(OH)2D, 4-OH-CB187, and BDE-47 are presented 
graphically in Figure 9.  
 
 
 
	   	   	  	   	  
	   34	  
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Orthogonal projections to latent structures (OPLS) regression VIP plot with important variables for 
the explanation of 1,25(OH)2D levels in female polar bears (Ursus maritimus) without cubs of the year 
(FWOCOY) (n = 15), from Svalbard. Variables with VIP > 1 are of high importance in the model. All variables 
are shown with default jack-knife confidence intervals, where larger intervals that cross the 0 line represent the 
lower reliability. For identification of abbreviations, see Table 1 (POPs) and Table 4 (THs). 
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Figure 8: Orthogonal projections to latent structures (OPLS) regression coefficient plot summarizing the 
relationship between the contaminant levels, TH levels, biological and environmental factors (X-variables) on 
plasma/serum 1,25(OH)2D levels (Y-variable) in female polar bears (Ursus maritimus) without cubs of the year 
(FWOCOY) (n = 15), from Svalbard. Negative coefficients represent inverse relationships and positive 
coefficients represent positive relationships of the X-variables with 1,25(OH)2D levels. Variables with the 
highest absolute coefficient values are considered to be most important in explaining the Y-variable 
1,25(OH)2D. Jack-knife confidence intervals that cross the 0 line indicate that the predictor is of low importance 
to the model. For identification of abbreviations, see Table 1 (POPs) and Table 4 (THs). 
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A)         B) 
 
Figure 9: The linear relationship (± 95% confidence interval) between 1,25(OH)2D serum concentrations 
(nmol/L) and A) 4-OH-CB187 (nmol/L) and B) BDE-47 (nmol/L) in female polar bears (Ursus maritimus) 
without cubs of the year (FWOCOY) (n = 15), from Svalbard, sampled in 2008. The Pearson correlation, p, and 
r-values are shown in the plot. 
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3.4.3 Males 
 
 
Principal Component analysis 
 
The analysis resulted in a PCA model (Figure 10) with 3 significant principal components. 
PC1 and PC2 explained 34.2 and 17.3 % of the variation, respectively (R2X = 0.650, Q2 = 
0.379). PC3 explained 13.5 % of the variation. Since all observations were within the 
Hotellings T2 range, no outliers were present. The loadings of PCA indicated that most of the 
contaminants were oriented along PC1 (PC1 = -0.18 – -0.14). The plasma/serum levels of  
1,25(OH)2D grouped closely together with cholesterol, p,p´-DDE, TT4 and trans-nonachlor, 
thus indicated a positive relationship between these. In addition, 1,25(OH)2D was negatively 
associated with TT3:TT4, FT4:TT4, age and several biometric variables (zygomatic width, 
BDI, estimated TBM and axillary girth). Head length was oriented towards the center of the 
plot, indicating that it was less important to the model. TT3, FT3, FT3:TT3 and FT4 were 
negatively associated with several PCBs (PCB-157, -170, -194, -189 and -206).  
 
Figure 10: PCA loading plot of the relationships among the observations and the variables in male polar bears 
(Ursus maritimus) (n = 20), from Svalbard. A total of 62 variables were included in the model; latitude, 
longitude, age, condition, straight length, axillary girth, head length, zygomatic width,  total body mass, body 
condition index, lipid content (%), cholesterol, 8 pesticides, 21 PCBs, 8 OH-PCBs, 5 PBDEs, THs and 
1,25(OH)2D. 
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Orthogonal Projections to Latent Structures (OPLS) 
  
To explore further the relations observed from the PCA-model, a single Y OPLS-model was 
applied to investigate the relationships between predictor variables (THs, contaminants, 
biological and environmental factors) and 1,25(OH)2D (Y) (Figure 11). Stepwise removal of 
the variables of least importance resulted in a significant model (Wold et al., 2001). The 
OPLS model predicted that the variation in 1,25(OH)2D was significantly explained by 20 
variables (R2X = 0.52, R2Y = 0.30 and Q2 = 0.19 , CV-ANOVA; p = 0.016). The highest VIP 
(variable importance in projection) values were shown by 4-OH-CB146, followed by PCB-
183, PCB-137, axillary girth, BDE-47, cholesterol, zygomatic width, lipid %, PCB-99, 
estimated total body mass (TBM) and body condition index (BCI)  (VIP > 1). Hence, these 
variables were considered to be the most important for explaining the variation in 
1,25(OH)2D. The coefficient plot showed that 4OH-CB146, PCB-183, PCB-137, BDE-47, 
cholesterol, lipid % and PCB-99 were positively correlated to 1,25(OH)2D. In contrast 
axillary girth, zygomatic width, estimated total body mass (TBM) and body condition index 
(BCI ) were inversely associated with 1,25(OH)2D levels in males (Figure 12). It should be 
noted that the validation parameters R2X and Q2 were below the value that defines a good 
model when using biological data; R2X > 0.7, Q2 > 0.4 (Lundstedt et al., 1998). 
 
Further testing, using bivariate correlations, showed that the only statistically significant 
correlations were between 1,25(OH)2D and TT3 (p = 0.013, rp = 0.545, n = 20) and between 
1,25(OH)2D  and TT4 (p = 0.028, rp = 0.492, n = 20). 
 
The linear relationships between 1,25(OH)2D, TT3 and TT4 are presented graphically in 
figure 13.  
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Figure 11: Orthogonal projections to latent structures (OPLS) regression VIP plot with important variables for 
the explanation of 1,25(OH)2D levels in male polar bears (Ursus maritimus) (n = 20), from Svalbard. Variables 
with VIP > 1 are of high importance in the model. All variables are shown with default jack-knife confidence 
intervals, where larger intervals that cross the 0 line represent the lower reliability. For identification of 
abbreviations, see Table 1 (POPs) and Table 5 (THs). 
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Figure 12: Orthogonal projections to latent structures (OPLS) regression coefficient plot summarizing the 
relationship between the contaminant levels, TH levels, biological and environmental factors (X-variables) on 
plasma/serum 1,25(OH)2D levels (Y-variable) in male polar bears (Ursus maritimus) (n = 20), from Svalbard. 
Negative coefficients represent inverse relationships and positive coefficients represent positive relationships of 
the X-variables with 1,25(OH)2D levels. Variables with the highest absolute coefficient values are considered to 
be most important in explaining the Y-variable 1,25(OH)2D. Jack-knife confidence intervals that cross the 0 line 
indicate that the predictor is of low importance to the model. For identification of abbreviations, see Table 1 
(POPs) and Table 5 (THs). 
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A)         B) 
 
Figure 13: The linear relationship (± 95% confidence interval) between 1,25(OH)2D serum concentrations 
(nmol/L) and A) TT3 (nmol/L) and B) TT4 (nmol/L) in male polar bears (Ursus maritimus) (n = 20) from 
Svalbard, sampled in 2008. The Pearson correlation, p, and r-values are shown in the plot. 
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4. Discussion 
 
 
The results of the present study show that circulating levels of 1,25(OH)2D did not differ 
significantly between the three groups of polar bears (Table 6). In addition, the study also 
shows that circulating concentrations of 1,25(OH)2D in polar bears may be disturbed by 
contaminants, and relationships between 1,25(OH)2D and THs were observed: POPs affected 
1,25(OH)2D levels in both FWCOY and FWOCOY, but not in males, while levels of THs 
affected 1,25(OH)2D levels in both FWCOY and males, but not in FWOCOY. 
 
 
4.1   Levels of vitamin D 
 
To my knowledge, this is the first study to examine circulating levels of 1,25(OH)2D in free-
ranging polar bears. Only a few studies have examined the plasma levels of vitamin D in 
polar bears (Crissey et al., 2001, Kenny et al., 1998, Kenny et al., 2004, Lin et al., 2005), and 
to my knowledge, none have investigated differences in vitamin D levels among females with 
and without cubs, and males. Only one previous study appear to have reported the serum 
levels of 1,25(OH)2D in (captive) polar bears (Crissey et al., 2001). The other studies have 
analyzed milk, serum or blubber levels of 25-OH vitamin D3 (25-OHD3) in polar bears. 
(Kenny et al., 1998, Kenny et al., 2004, Lin et al., 2005). 25-OHD3 is metabolized in the liver 
from 7-dehydrocholesterol, before further metabolized in the kidneys to the active compound 
1,25(OH)2D (Vieth, 2005). Lin et al (2005) investigated associations between serum levels of 
25-OHD3 in captive polar bears and antebrachial fractures, and reported subnormal vitamin D 
concentrations in 2 of 3 polar bears with fractures. Kenny et al (1998) reported 25-OHD3 
levels in milk from captive and free-ranging polar bears, and later they investigated the 25-
OHD3 content in polar bear blubber (Kenny et al., 2004). Due to the lack of a reliable 
kidney/milk/blubber-to-blood conversion factor for 25-OHD3 to 1,25(OH)2D in polar bears, a 
direct comparison of levels between the present study (plasma 1,25(OH)2D) and previous 
studies (blubber/milk/plasma 25-OHD3) is not possible. In the present study, the plasma 
	   	   	  	   	  
	   43	  
concentrations of 1,25(OH)2D (Table 3, 4 and 5) were higher (mean = 0.68 nmol/L) than 
previously reported 1,25(OH)2D levels in captive polar bears (mean = 0.045 nmol/L) (Crissey 
et al., 2001). The higher plasma concentrations in the present free-ranging polar bears, could 
be due to different analytical methods, or that the low concentrations reported by Crissey et 
al. (2001) is due to artificial captivity factors. Levels of 1,25(OH)2D in the present polar 
bears were similar to those reported in gray seals (Halichoerus grypus) (mean = 1.14 nmol/L) 
and ringed seal (Phoca hispida botnica) (mean = 0.26 nmol/L) (Routti et al., 2008). It should 
however be noted that species differences are likely to exist in marine mammals. These 
comparative physiological differences are not adressed in the current thesis. 
 
Normally, circulating 1,25(OH)2D levels are strictly controlled (Vieth, 2005) and have been 
reported to remain stable in hooded seals (Cystophora cristata) during vitamin D 
supplementation (Keiver et al., 1988). Furthermore, plasma levels have been shown not to 
vary during the molting season in southern elephant seals (Mirounga leonina) (Wilske & 
Arnbom, 1996). This indicates that circulating 1,25(OH)2D levels are strictly controlled 
independent of some natural physiological constrains. However, the circulating levels of 
1,25(OH)2D levels in Baltic ringed seals (Phoca hispida botnica), with high body burdens of 
organochlorinated pollutants, were significantly lower than in ringed seals from two lesser 
contaminated areas (Sable Island, Canada and Svalbard, Norway) (Routti et al., 2008). It 
should, however, also be noted that the Baltic ringed seals had higher levels of hepatic 
vitamin D3 than the reference seals (Canada and Norway), and did not suffer from vitamin D3 
deficiency.  
 
 
4.2   Thyroid hormone levels 
 
In FWCOY, the levels of all THs were significantly higher than in males (Table E.1, 
Appendix). In FWOCOY, levels of TT4 and FT4 were also significantly higher than in 
males. As discussed later, this could be due to the differences in contaminant levels between 
the three groups of polar bears, or due to physiological differences between the groups.  
There were no significant differences between the two female groups of polar bears with 
regards to the THs (Table E.1). 
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In the present study, the reported levels of THs measured in plasma of FWCOY (TT4: 18.57 
± 6.16 nmol/L, FT4: 7.04 ± 2.21 pmol/L, TT3: 1.10 ± 0.19 nmol/L, FT3: 0.40 ± 0.24) are 
comparable with previous reported concentrations of THs in FWCOY at Svalbard sampled in 
2008 ((Nilsen, 2011); TT4: 18.8 ± 5.9 (nmol/L), FT4: 7.4 ± 2.1 (pmol/L), TT3: 1.2 ± 0.1 
(nmol/L), FT3: 0.5 ± 0.2 (pmol/L)). It should be noted that the present study and that 
particular study contained some of the same individuals. Thus, the similarities in TH levels 
between these studies were expected. There have not been any reports of plasma TH 
concentrations in female polar bears without cubs or in male polar bears from Svalbard 
during the latest years. However, Braathen et al. (2004) reported levels of plasma THs in the 
same three groups of polar bears as in the present study, sampled in 1997/1998 (FWCOY: 
TT4: 15.3 nmol/L; FT4: 4.38 pmol/L; TT3: 1.26 nmol/L; FT3: 1.26 pmol/L; FWOCOY: 
TT4: 18.5 nmol/L; FT4: 5.20 pmol/L; TT3: 1.58 nmol/L; FT3: 1.42 pmol/L; males: TT4: 
13.5  nmol/L; FT4: 3.46 pmol/L; TT3: 1.23 nmol/L; FT3: 0.95 pmol/L).  Levels of TT4 and 
FT4 were higher in FWCOY in the present study compared with the levels reported in 
FWCOY in 1997/1998 (Braathen et al., 2004). Among FWOCOY and males, levels of FT4 
in the present study were also higher than reported in 1997/1998. Furthermore, levels of TT4 
in the present study were lower in FWOCOY and males than in 1997/1998. For FWCOY and  
FWOCOY, levels of TT3 were about the same in 2008 and in 1997/1998. Levels of FT3 were 
about the same for FWCOY. In FWOCOY the levels of FT3 were lower in the present study 
than in 1997/1998. For males, TT3 and FT3 were both lower in the present study than in 
1997/1998. 
 
POPs have been shown to disrupt the TH homeostasis in polar bears (Braathen et al., 2004, 
Legler & Brouwer, 2003, Meerts et al., 2001, Verreault et al., 2005a). However, the levels of 
PCBs in polar bears from Svalbard have decreased the past years (Bytingsvik et al., 2012, 
Verreault et al., 2005b). Taking into consideration that several factors influence thyroid 
hormone levels, from food availability, iodine access, season, age, even time of day 
(McNabb, 2000), it may not be appropriate to draw conclusions on TH levels being higher or 
lower in this study compared to other studies. On the other hand, when concidering previous 
reported TH levels in polar bears from Svalbard (Braathen et al., 2004, Skaare et al., 2001), 
where plasma was sampled during March and April 1991-1994 (Skaare et al., 2001) and 
during the same time in 1997-1998 (Braathen et al., 2004) the same trend as in the present 
study appears. When taking into account that levels of organohalogenated compounds in 
polar bears have decreased significantly during this period (Bytingsvik et al., 2012), this may 
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indicate that there is a link between contaminant levels and THs in polar bears, as previously 
suggested by Skaare et al. (2001) and Braathen et al. (2004). 
 
In the present study, FWCOY had significant higher levels of all the THs than males, and the 
levels of TT4 and FT4 were significantly higher in FWOCOY compared with males (Table 
E.1). In the study by Skaare et al. (2001) the concentrations of thyroid hormones (TT4, FT4 
and FT3) were significantly higher in females than in males. Skaare et al. (2001) did not 
distinguish between females with and without cubs, as in the present study. In the study by 
Braathen et al. (2004) they did distinguish between the groups of polar bears, and they 
reported higher levels of TT3 in FWOCOY, compared to both males and FWCOY, while 
there were no differences in FT3 levels between the groups. In conclusion, the results on 
differences in THs between the groups are generally in accordance with previously reported 
studies (Braathen et al., 2004, Skaare et al., 2001). It is therefore concluded that the higher 
levels of THs in females compared to males, is due to sex-differences in regulatory 
mechanisms of THs in polar bears.  
 
Elevated TH levels have been related to an increase in bone resorption and reduction in bone 
mineral density (Lind et al., 2003). In humans, hyperthyroidism has been associated with 
osteoporosis (Lakatos, 2003), and thyroid deseases are more common in women than in men, 
thus women are more likely to develop hypothyroidism, both overt and subclinically 
(Chiovato et al., 1993, Krueger et al., 2001). Gray seals from British waters have also been 
suggested to suffer from contaminant-mediated hyperthyroidism (Hall et al., 2003). Thus it is 
possible that the higher incidence of TH imbalance found in female polar bears (Braathen et 
al., 2004) compared with males could reflect the greater susceptibility of female polar bears 
to TH-related effects of POPs. 
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4.3   Prevalence and patterns of POPs 
 
Polar bears at Svalbard are reported as one of the polar bear population with highest 
contamination load (de Wit et al., 2004). In the present study the most abundant contaminant 
group was OH-PCBs, followed by PCBs, pesticides and PBDEs (Table 7, 8 and 9). This 
reflect the general pattern of POPs reported in Arctic mammals and in polar bear plasma 
(Letcher et al., 2010). It should be noted that although the PBDEs constituted only 0.2 - 0.28 
% of the total POP load in the three groups of polar bears, they were among the most 
important explanatory variables regarding the variation in 1,25(OH)2D. However, since three 
out of five PBDEs were suspected to have high background levels, these results should be 
considered as semi-quantitative. 
 
The major compound group detected in the present study in polar bear plasma was OH-PCBs 
(Table 7), where FWCOY had the highest levels. 4-OH-CB187 was the main contributor to 
ΣOH-PCBs, and levels in females were almost 2 fold higher as compared to in males. In 
females, the componds found in second and third highest concentrations among the OH-
PCBs were 4-OH-CB146 and 4´OH-CB172. For males 4´OH-CB172 and 4-OH-CB146 had 
the second and third highest concentrations, respectively. The concentrations of 4´OH-CB172 
were higher in males than in females, while levels of 4-OH-CB146 were less than half in 
males as compared to in females. In all bears, there were detected significant concentrations 
of co-eluting peak consisting of 4´OH-CB172 and another hepta-chlorinated OH-PCB 
isomer, Cl7-OH-PCB (4´OH-CB172/Cl7-OH-PCB). Of these, Cl7-OH-PCB was the 
dominating isomer. 4´OH-CB172 has been detected in earlier polar bear studies  (Sandala et 
al., 2004, Sandau et al., 2000). However, for significant results regarding 4´OH-CB172/Cl7-
OH-PCB, it should be taken into concideration that Cl7-OH-PCB seemed to be the causative 
compound.  The levels of OH-PCBs in females were similar to those previously reported by 
Bytingsvik et al. (2012). Since many of the individuals in that particular study and the present 
study were the same, this was expected. The metabolic capacity has been reported to be age-
dependent, where female polar bears were better capable to metabolize PCBs into OH-PCBs 
compared to polar bear cubs (Bytingsvik et al., 2012).  
 
The second most abundant compound group was PCBs, with PCB-153 as the main 
contributor for all three groups of polar bears. PCB-180 and PCB-170 had the second and 
third highest concentrations in all groups. The following compound group was the pesticides 
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(Table 8). Oxychlordane was main contributor in the females, while HCB had highest levels 
in males.  Oxychlordane-levels was 7-8 fold higher in females compared to males. The levels 
of the other pesticides were comparable between the three groups of polar bears. PBDEs was 
the compound group with the lowest concentrations in the polar bear plasma from all three 
groups (Table 9). BDE-47 was the main contributor to ΣPBDE in the female groups, and 
BDE-183 was the main contributor in males. BDE-47 levels were 2-3 fold lower in males 
compared to FWCOY and FWOCOY. The pattern of the other PBDE congeners varied 
between the three groups. The reason for these differences may be due to the reported high 
background levels, or due to maternal transfer of POPs and/or group differences in capacity 
to metabolize the PBDEs (i.e P450 enzyme activities), or exposure related to diet differences 
between the groups (McKinney et al., 2009). Because elucidating differences in contaminant 
burdens between groups was not the main aim of the present study, these aspects are not 
discussed further. Thus, the reader is referred to Letcher et al. (2010) for a more detailed 
discussion of these aspects. 
  
In the present study, negative relationships between biometric variables and mainly OH-
PCBs were detected for FWOCOY (Figure 6). Age was inversely correlated with 4-OH-
CB146, 3´OH-CB138 and 3´OH-CB180. Since the contaminants are persistent, it was 
expected that age would be positively correlated with some of the POPs. The inverse 
relationship between age and the above mentioned OH-PCBs may be due to concentration 
dependent toxicokinetics or age related changes in the metabolism of PCBs to OH-PCBs. 
However, the focus of the present study was to elucidate the combined effects of POPs, THs 
and biometric and environmental variables on 1,25(OH)2D levels. Thus, associations 
between POPs and biometric variables are not discussed in more detail herein.  
 
 
4.4   Effects of POPs, THs and biometric variables on  
        vitamin D 
 
Both biometric variables, POPs and THs affected 1,25(OH)2D levels. However, there were 
large differences between the groups. In the OPLS model for FWCOY, there was a strong 
inverse correlation between 1,25(OH)2D, and BDE-153 and HCB, while there were positive 
correlations between 1,25(OH)2D, and age, TT4, zygomatic width, FT4, FT3, and FT3:TT3 
(Figure 4). In the OPLS model for FWOCOY, several of the POPs correlated positively with 
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1,25(OH)2D, while none of the THs were correlated with 1,25(OH)2D. Oxychlordane, 
p,p´DDE, PCBs (-47, -128, -189), 4´OH-CB172, 3´OH-CB138, 4-OH-CB187, BDE-47, and 
BDE-154 were positively correlated to 1,25(OH)2D, while BDE-209 were negatively 
correlated to 1,25(OH)2D in FWOCOY (Figure 8). In the OPLS model for males, none of the 
contaminants correlated significantly with levels of 1,25(OH)2D. However, TT3 and TT4 
were positively correlated with 1,25(OH)2D (Figure 12). 
 
In the OPLS models for all groups, OH-PCBs seemed to be important predictors for the 
circulating levels of 1,25(OH)2D. It is known that OH-PCBs are thyroid endocrine disrupters, 
and the results from the present study may indicate that they also are important vitamin D 
disruptors. To my knowledge this has not been reported previously. As discussed below, it is 
possible that there are interacting effects of OH-PCBs and THs on levels of 1,25(OH)2D. 
Routti et al. (2008) has previously reported that levels of circulating 1,25(OH)2D and THs 
were negatively related with hepatic levels of POPs. It has also been suggested that low 
levels of 1,25(OH)2D could be compensated for by elevated TH levels (Mohan et al., 2004), 
or that excess THs results in a decrease in 1,25(OH)2D production (Epstein & Schneider, 
2005). However, in the present study, THs was shown not to be a predictor for the levels of 
1,25(OH)2D in FWOCOY. This may indicate that the interacting effects between POPs and 
THs on 1,25(OH)2D, not necessarily are related to THs and their role in the regulation of 
vitamin D. The OPLS models indicates that POPs played a larger role for the concentrations 
of 1,25(OH)2D in FWOCOY, than in FWCOY and in males. The reason for this is not known 
but may, as discussed below, be due to the differences in the physiology between the groups. 
 
Previously, levels of THs have shown to be both positively and negatively related with POP 
levels in polar bears (Braathen et al., 2004, Skaare et al., 2001), and levels of 1,25(OH)2D 
have been reported to be negatively associated with POPs levels in ringed seals (Routti et al., 
2008). Previous studies have suggested that excess TH levels may cause a reduction in 
1,25(OH)2D levels (Epstein & Schneider, 2005), and that low levels of 1,25(OH)2D may lead 
to elevated TH levels (Mohan et al., 2004). However, it is possible that there is complex 
relationships in which POPs can lead to reduced levels of TH, as shown for FWCOY in the 
present study, and that this is a contributing factor to reduced vitamin D levels in this group. 
However, the OPLS models showed that in males and in FWOCOY, THs played little or no 
role in explaining the variations in levels of 1,25(OH)2D, respectively. This may indicate that 
THs plays a larger role for the vitamin D homeostasis (i.e. 1,25(OH)2D plasma 
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concentrations) in FWCOY than in the other groups. This could be related to the 
physiological status of this group, possibly in relation to lactation, and/or that they recover 
from giving birth to the cubs in the den during the winter. In this study it is not possible to 
give an exact explanaition of possible mechanisms involved in the combined effects of POPs 
and THs on plasma concentrations of 1,25(OH)2D in polar bears.  
 
In FWCOY, age and size (zygomatic width) seemed to be a relatively strong predictor of 
levels of 1,25(OH)2D. In contrast, biometric variables were less important for FWOCOY. In 
males, several biometric variables (age, size [BCI and zygomatic width]) and  physiological 
variables such as lipid % and cholesterol were important predictors in explaining 1,25(OH)2D 
levels. This indicates that the biometric variables, in interaction with POPs, affect levels of 
1,25(OH)2D, especially in FWCOY and males. In addition, the result indicates that for these 
two groups (FWCOY and males), a more complex interaction exists, were levels of 
1,25(OH)2D is affected by both THs, biometric variables (particularly age and size) and 
POPs. 
 
It is challenging to elucidate effects from POPs on wildlife. The sample size in each of the 
groups in the present study represent a small section of polar bears from the population at 
Svalbard. The present study focus on effect assessment in three groups of polar bears, and it 
is therefore possible to assess differences in levels and effects between sexes. However, there 
is limited knowledge about the life history and generel physiological conditions of these 
randomly captured individuals. The period the study was conducted represents a short time 
window of the polar bear life cycle; in addition there are logistical constraints associated with 
the study area and season. Arctic biota is exposed to a complex mixture of anthropogenic 
contaminants, of which the quantitatively and qualitatively composition is not fully 
elucidated (de Wit et al., 2004). For instance, the POPs analysed in the present study 
represents a selection of compounds within a selection of all compound groups that polar 
bears are exposed to. For this reason, it is not possible to account for the possible interactions 
from non-analysed contaminants in the present study. Furthermore, the contaminants in the 
present study showed a high degree of covariation. Such strong intercorrelations in a dataset 
can complicate the multivariate data analysis when elucidating responses (Trygg & Wold, 
2002). Multivariate data analysis methods, such as the OPLS, are developed to better handle 
the challenges regarding intercorrelations between variables. However, there are still 
uncertainties associated with the interpretation of data. For instance, the non-analysed 
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compounds may contribute to the observed indications of effects on 1,25(OH)2D, while 
others merely covary with the compound explaining the variation. Since no one previously 
have analysed levels of 1,25(OH)2D in polar bears from Svalbard, it is not possible to 
conclude on a time trend for polar bears with regards to plasma concentrations of vitamin D, 
even though we know that the levels of POPs are declining. When assessing levels and 
effects of POPs in polar bears, it is essential to allow for differences in tissue, analysis 
procedures, data handling, sample size and study area. As strongly indicated in the present 
study, dissimilarities between sexes, species, lipid content and time of sampling should also 
be considered.  
 
The present study documents that there are complex interactions between POPs, THs and 
biometric variables on the 1,25(OH)2D status in polar bears, and that there are differences in 
the importance of these different predictors in FWCOY, FWOCOY and males. It is proposed 
that the differences in the importance of the various predictors, is due to the very different 
physiology of the animals. By nature, males and females have a completely different genetic 
physiology and hormone regulation. It is also likely that there are large differences in 
physiology between FWCOY and FWOCOY. FWCOY have been fasting in the den during 
the winter, and were lactating actively when sampled. It is likely that this affected the 
complex interactions of POPs, THs and biometric variables on 1,25(OH)2D levels differently 
in the two groups of females. Furthermore, the sampled FWOCOY had essentially stopped 
lactating, and had probably not fasted to the same extent throughout the winter (because they 
do not go to den). They are therefore not prone to the same physiological stress that FWCOY, 
and it is possible that this could explain the differences in the complex relationships between 
POPs, THs and biometric variables on 1,25(OH)2D in these two groups of female polar bears. 
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5. Conclusions 
 
 
In conclusion, the present study strongly indicates that there are interactive effects of plasma 
levels of POPs and plasma levels of THs on plasma levels of 1,25(OH)2D in polar bears. 
There were, however, some differences between the three groups of polar bears. Thus, the 
present study demonstrates that it is important to take into account differences in sex and life 
stages when assessing endocrine effects of POPs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   	   	  	   	  
	   52	  
 
 
 
Bibliography 
 
 
AMAP, 1998. AMAP Assessment Report: Arctic Pollution Issues. Oslo, Norway. Arctic Monitoring 
and Assessment Programme, 859 pp. 
 
Baylink D, Stauffer M, Wergedal J, Rich C, 1970. Formation, mineralization, and resorption of bone 
in vitamin D-deficient rats. Journal of Clinical Investigation, 49: 1122-1134. 
 
Bergman A, Olsson M, Reiland S, 1992. Skull-bone lesions in the Baltic grey seal  (Halichoerus 
grypus). Ambio, 21: 517-519. 
 
Bernhoft A, Wiig O, Skaare JU, 1997. Organochlorines in polar bears (Ursus maritimus) at Svalbard. 
Environmental Pollution, 95: 159-175. 
 
Berson SA, Yalow RS, 1968. General principles of radioimmunoassay. Clinica Chimica Acta, 22: 51-
69. 
 
Bertinussen HO, 2009. Effects of hydroxylated PCBs on thyroid hormone levels in mother-cub pairs 
of polar bears (Ursus maritimus) from Svalbard. MSc Thesis, Norwegian University of 
Science and Technology.  
 
Boas M, Feldt-Rasmussen U, Skakkebæk NE, Main KM, 2006. Environmental chemicals and thyroid 
function. European Journal of Endocrinology, 154: 599-611. 
 
Borgå K, Fisk AT, Hoekstra PF, Muir DCG, 2004. Biological and chemical factors of importance in 
the bioaccumulation and trophic transfer of persistent organochlorine contaminants in Arctic 
marine food webs. Environmental Toxicology and Chemistry, 23: 2367-2385. 
 
Braathen M, Derocher AE, Wiig O, Sormo EG, Lie E, et al., 2004. Relationships between PCBs and 
thyroid hormones and retinol in female and male polar bears. Environmental Health 
Perspectives, 112: 826-833. 
 
Braune BM, Outridge PM, Fisk AT, Muir DC, Helm PA, et al., 2005. Persistent organic pollutants 
and mercury in marine biota of the Canadian Arctic: An overview of spatial and temporal 
trends. The Science of the Total Environment, 351-352: 4-56. 
 
Brevik EM, 1978. Gas chromatograhic method for the determination of organochlorine pesticides in 
human milk. Bulletin of Environmental Contamination and Toxicology, 19: 281-286. 
 
Bustnes JO, Fauchald P, Tveraa T, Helberg M, Skaare JU, 2008. The potential impact of 
environmental variation on the concentrations and ecological effects of pollutants in a marine 
avian top predator. Environment International, 34: 193-201. 
 
Bustnes JO, Gabrielsen GW, Verreault J, 2010. Climate variability and temporal trends of persistent 
organic pollutants in the Arctic: A study of glaucous gulls. Environmental Science & 
Technology, 44: 3155-3161. 
 
Bytingsvik J, Lie E, Aars J, Derocher AE, Wiig Ø, Jenssen BM, 2012. PCBs and OH-PCBs in polar 
bear mother-cub pairs: A comparative study based on plasma levels in 1998 and 2008. The 
Science of the Total Environment, 417-418: 117-128. 
	   	   	  	   	  
	   53	  
Calvert W, Ramsay MA, 1998. Evaluation of age determination of polar bears by counts of cementum 
growth layer groups. Ursus, 10: 449-453. 
 
Cattet MRL, Caulkett NA, Obbard ME, Stenhouse GB, 2002. A body-condition index for ursids. 
Canadian Journal of Zoology, 80: 1156-1161. 
 
Chiovato L, Lapi P, Fiore E, Tonacchera M, Pinchera A, 1993. Thyroid autoimmunity and female 
gender. Journal of Endocrinological Investigation, 16: 384-391. 
 
Christensen-Dalsgaard SN, Aars J, Andersen M, Lockyer C, Yoccoz NG, 2010. Accuracy and 
precision in estimation of age of Norwegian Arctic polar bears (Ursus maritimus) using 
dental cementum layers from known-age individuals. Polar Biology, 33: 589-597. 
 
Crissey S, Ange K, Slifka K, Bowen P, Stacewicz-Sapuntzakis M, et al., 2001. Serum concentrations 
of vitamin D metabolites, vitamins A and E, and carotenoids in six canid and four ursid 
species at four zoos. Comparative Biochemistry and Physiology, Part A: Molecular & 
Integrative Physiology, 128: 155-165. 
 
Dawson A, 2000. Mechanisms of endocrine disruption with particular reference to occurrence in 
avian wildlife: A review. Ecotoxicology, 9: 59-69. 
 
de March B, de Wit C, Muir D, Braune B, Gregor D, et al., 1998. Persistent organic pollutants. In: 
AMAP Assessment Report: Arctic Pollution Issues. Arctic Monitoring and Assessment 
Programme. Oslo, Norway, 183-373 pp. 
 
de Wit CA, Herzke D, Vorkamp K, 2010. Brominated flame retardants in the Arctic environment-
trends and new candidates. Science of the Total Environment, 408: 2885-2918. 
 
de Wit CA, Fisk AT, Hobbs KE, Muir DCG, Gabrielsen GW, et al., 2004. AMAP Assessment 2002: 
Persistent organic pollutants in the Arctic. Arctic Monitoring and Assessment Programme. 
Oslo, Norway. 
 
Derocher AE, Wiig Ø, 2002. Postnatal growth in body length and mass of polar bears (Ursus 
maritimus) at Svalbard. Journal of Zoology, 256: 343-349. 
 
Derocher AE, Wiig Ø, Andersen M, 2002. Diet composition of polar bears in Svalbard and the 
western Barents Sea. Polar Biology, 25: 448-452. 
 
Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, et al., 2009. Endocrine-
disrupting chemicals: An endocrine society scientific statement. Endocrine Reviews, 30: 293-
342. 
 
Epstein S, Schneider A, 2005. Drug and hormone effects on vitamin D metabolism. In: Feldman D, 
Pike JW, Glorieux FH, eds. Vitamin D. Elsevier Academic Press, San Diego, CA, USA, 1253-
1291 pp. 
 
Eriksson L, Johansson E, Kettaneh-Wold N, Wold S, 2006. Multi-and megavariate data analysis. 
Part I: Basic Principles and applications. 2nd edition. Umeå: Umetrics.  
 
Faibish D, Boskey AL, 2005. Mineralization. In: Feldman D, Pike JW, Glorieux FH, eds. Vitamin D. 
Elsevier Academic Press, San Diego, CA, USA, 477-495 pp. 
 
Haave M, Ropstad E, Derocher AE, Lie E, Dahl E, et al., 2003. Polychlorinated biphenyls and 
reproductive hormones in female polar bears at Svalbard. Environmental Health Perspectives, 
111: 431-436. 
 
Hall AJ, Kalantzi OI, Thomas GO, 2003. Polybrominated diphenyl ethers (PBDEs) in grey seals 
during their first year of life-are they thyroid hormone endocrine disrupters? Environmental 
Pollution, 126: 29-37. 
	   	   	  	   	  
	   54	  
Hop H, Borgå K, Gabrielsen GW, Kleivane L, Skaare JU, 2002. Food web magnification of persistent 
organic pollutants in poikilotherms and homeotherms from the Barents Sea. Environmental 
Science & Technology, 36: 2589-2597. 
 
Horst RL, Reinhardt TA, Reddy GS, 2005. Vitamin D Metabolism. In Feldman D, Pike JW, Glorieux 
FH, eds. Vitamin D. Elsevier Academic Press, London, United Kingdom, 15-36 pp. 
 
Jenssen BM, 2006. Endocrine-disrupting chemicals and climate change: A worst-case combination 
for Arctic marine mammals and seabirds? Environmental Health Perspectives, 114: 76-80. 
 
Jones KC, De Voogt P, 1999. Persistent organic pollutants (POPs): State of the science. 
Environmental Pollution, 100: 209-221. 
 
Kato Y, Haraguchi K, Ito Y, Fujii A, Yamazaki T, et al., 2010. Polychlorinated biphenyl-mediated 
decrease in serum thyroxine level in rodents. Drug Metabolism and Disposition, 38: 697-704. 
 
Keiver KM, Draper H, Ronald K, 1988. Vitamin D metabolism in the hooded seal (Cystophora 
cristata). The Journal of Nutrition, 118: 332-341. 
 
Kelly BC, Ikonomou MG, Blair JD, Morin AE, Gobas FA, 2007. Food web-specific biomagnification 
of persistent organic pollutants. Science, 317: 236-239. 
 
Kenny DE, Irlbeck NA, Chen TC, Lu Z, Holick MF, 1998. Determination of vitamins D, A, and E in 
sera and vitamin D in milk from captive and free‐ranging polar bears (Ursus maritimus), and 
7‐dehydrocholesterol levels in skin from captive polar bears. Zoo Biology, 17: 285-293. 
 
Kenny DE, O'Hara TM, Chen TC, Lu Z, Tian X, Holick MF, 2004. Vitamin D content in Alaskan 
Arctic zooplankton, fishes, and marine mammals. Zoo Biology, 23: 33-43. 
 
Krueger PD, Raina P, Braun EA, Patterson C, Chambers LW, 2001. Prevalence and risk factors of 
hypothyroidism: Findings from the Canadian study of health and aging. Canadian Journal on 
Aging, 20: 127-135. 
 
Lakatos P, 2003. Thyroid hormones: Beneficial or deleterious for bone? Calcified Tissue 
International, 73: 205-209. 
 
Legler J, Brouwer A, 2003. Are brominated flame retardants endocrine disruptors? Environment 
International, 29: 879-885. 
 
Letcher RJ, Norstrom RJ, Muir DCG, 1998. Biotransformation versus bioaccumulation: Sources of 
methyl sulfone PCB and 4,4'-DDE metabolites in the polar bear food chain. Environmental 
Science & Technology, 32: 1656-1661. 
 
Letcher RJ, Bustnes JO, Dietz R, Jenssen BM, Jørgensen EH, et al., 2010. Exposure and effects 
assessment of persistent organohalogen contaminants in Arctic wildlife and fish. The Science 
of the Total Environment, 408: 2995-3043. 
 
Lie E, Larsen HJrS, Larsen S, Johansen GM, Derocher AE, et al., 2004. Does high organochlorine 
(OC) exposure impair the resistance to infection in polar bears (Ursus maritimus)? Part I: 
Effect of OCs on the humoral immunity. Journal of Toxicology and Environmental health, 
Part A, 67: 555-582. 
 
Lilienthal H, Fastabend A, Hany J, Kaya H, Roth-Härer A, et al., 2000. Reduced levels of 1,25-
dihydroxyvitamin D3 in rat dams and offspring after exposure to a reconstituted PCB 
mixture. Toxicological Sciences, 57: 292-301. 
 
Lin RC, Engeli E, Prowten AW, Erb HN, Ducharme NG, Goodrich LR, 2005. Antebrachial fractures 
in four captive polar bears (Ursus maritimus). Veterinary Surgery, 34: 358-365. 
 
	   	   	  	   	  
	   55	  
Lind PM, Bergman A, Olsson M, Örberg J, 2003. Bone mineral density in male Baltic grey seal 
(Halichoerus grypus). Ambio, 32: 385-388. 
 
Lundstedt T, Seifert E, Abramo L, Thelin B, Nyström Å, et al., 1998. Experimental design and 
optimization. Chemometrics and Intelligent Laboratory Systems, 42: 3-40. 
 
McKinney MA, Peacock E, Letcher RJ, 2009. Sea ice-associated diet change increases the levels of 
chlorinated and brominated contaminants in polar bears. Environmental Science & 
Technology, 43: 4334-4339. 
 
McNabb FMA, 1992. Thyroid hormones: production, storage, and release by the thyroid gland. In: 
Thyroid Hormones. Prentice Hall, Englewood Cliffs, NJ, USA, 21-48 pp.  
 
McNabb FMA, 2000. Thyroids. In: Sturkie’s Avian Physiology (Whittow GC, ed). 5th ed. London, 
Academic Press, 461-471 pp.  
 
Meerts I, Letcher RJ, Hoving S, Marsh G, Bergman A, et al., 2001. In vitro estrogenicity of 
polybrominated diphenyl ethers, hydroxylated PDBEs, and polybrominated bisphenol A 
compounds. Environmental Health Perspectives, 109: 399-407. 
 
Merryman JI, Buckles EL, 1998. The avian thyroid gland. Part two: A review of function and 
pathophysiology. Journal of Avian Medicine and Surgery: 12: 238-242. 
 
Miljeteig C, Strøm H, Gavrilo MV, Volkov A, Jenssen BM, Gabrielsen GW, 2009. High levels of 
contaminants in ivory gull (Pagophila eburnea) eggs from the Russian and Norwegian Arctic. 
Environmental Science & Technology, 43: 5521-5528. 
 
Mohan HK, Groves AM, Fogelman I, Clarke SE, 2004. Thyroid hormone and parathyroid hormone 
competing to maintain calcium levels in the presence of vitamin D deficiency. Thyroid, 14: 
789-791. 
 
Murvoll KM, Jenssen BM, Skaare JU, 2005. Effects of pentabrominated diphenyl ether (PBDE-99) 
on vitamin status in domestic duck (Anas platyrhynchos) hatchlings. Journal of Toxicology 
and Environmental Health, Part A, 68: 515-533. 
 
Murvoll KM, Skaare JU, Anderssen E, Jenssen BM, 2006. Exposure and effects of persistent organic 
pollutants in European shag (Phalacrocorax aristotelis) hatchlings from the coast of Norway. 
Environmental Toxicology and Chemistry, 25: 190-198. 
 
Nilsen EME, 2011. Temporal change and effects of perfluoroalkyl substanses (PFASs) on thyroid 
hormone levels in mother-cub pairs of polar bear (Ursus maritimus) from Svalbard in 1998 
and 2008. MSc Thesis, Norwegian University of Science and Technology. 
 
Olsen GH, Mauritzen M, Derocher AE, Sørmo EG, Skaare JU, et al., 2003. Space-use strategy is an 
important determinant of PCB concentrations in female polar bears in the Barents Sea. 
Environmental Science & Technology, 37: 4919-4924. 
 
Oskam IC, Ropstad E, Dahl E, Lie E, Derocher AE, et al., 2003. Organochlorines affect the major 
androgenic hormone, testosterone, in male polar bears (Ursus maritimus) at Svalbard. Journal 
of Toxicology and Environmental Health, Part A, 66: 2119-2139. 
 
Routti H, Nyman M, Jenssen BM, Bäckman C, Koistinen J, Gabrielsen GW, 2008. Bone‐related 
effects of contaminants in seals may be associated with vitamin D and thyroid hormones. 
Environmental Toxicology and Chemistry, 27: 873-880. 
 
Sandala G, Sonne-Hansen C, Dietz R, Muir D, Valters K, et al., 2004. Hydroxylated and methyl 
sulfone PCB metabolites in adipose and whole blood of polar bear (Ursus maritimus) from 
East Greenland. The Science of the Total Environment, 331: 125-141. 
 
	   	   	  	   	  
	   56	  
Sandau CD, Meerts IATM, Letcher RJ, McAlees AJ, Chittim B, et al., 2000. Identification of 4-
hydroxyheptachlorostyrene in polar bear plasma and its binding affinity to transthyretin: A 
metabolite of octachlorostyrene? Environmental Science & Technology, 34: 3871-3877. 
 
Skaare JU, Bernhoft A, Wiig Ø, Norum KR, Haug E, et al., 2001. Relationships between plasma 
levels of organochlorines, retinol and thyroid hormones from polar bears (Ursus maritimus) at 
Svalbard. Journal of Toxicology and Environmental Health, Part A, 62: 227-241. 
 
Sonne C, Leifsson PS, Dietz R, Erik W, Letcher RJ, et al., 2006. Xenoendocrine pollutants may 
reduce size of sexual organs in East Greenland polar bears (Ursus maritimus). Environmental 
Science & Technology, 40: 5668-5674. 
 
Sørmo EG, Jussi I, Jussi M, Braathen M, Skaare JU, Jenssen BJM, 2005. Thyroid hormone status in 
gray seal (Halichoerus grypus) pups from the Baltic Sea and the Atlantic Ocean in relation to 
organochlorine pollutants. Environmental Toxicology and Chemistry, 24: 610-616. 
 
Sørmo EG, Salmer MP, Jenssen BM, Hop H, Baek K, et al., 2006. Biomagnification of 
polybrominated diphenyl ether and hexabromocyclododecane flame retardants in the polar 
bear food chain in Svalbard, Norway. Environmental Toxicology and Chemistry, 25: 2502-
2511. 
 
Stirling I, Spencer C, Andriashek D, 1989. Immobilization of polar bears (Ursus maritimus) with 
Telazol in the Canadian Arctic. Journal of Wildlife Diseases, 25: 159-168. 
 
Trygg J, Wold S, 2002. Orthogonal projections to latent structures (O‐PLS). Journal of 
Chemometrics, 16: 119-128. 
 
Verreault J, Skaare JU, Jenssen BM, Gabrielsen GW, 2004. Effects of organochlorine contaminants 
on thyroid hormone levels in Arctic breeding glaucous gulls (Larus hyperboreus). 
Environmental Health Perspectives, 112: 532-537. 
 
Verreault J, Gabrielsen GW, Chu S, Muir DCG, Andersen M, et al., 2005a. Flame retardants and 
methoxylated and hydroxylated polybrominated diphenyl ethers in two Norwegian Arctic top 
predators: glaucous gulls and polar bears. Environmental Science & Technology, 39: 6021-
6028. 
 
Verreault J, Muir DCG, Norstrom RJ, Stirling I, Fisk AT, et al., 2005b. Chlorinated hydrocarbon 
contaminants and metabolites in polar bears (Ursus maritimus) from Alaska, Canada, East 
Greenland, and Svalbard: 1996-2002. The Science of the Total Environment, 351: 369-390. 
 
Verreault J, Bech C, Letcher RJ, Ropstad E, Dahl E, Gabrielsen GW, 2007. Organohalogen 
contamination in breeding glaucous gulls from the Norwegian Arctic: Associations with basal 
metabolism and circulating thyroid hormones. Environmental Pollution, 145: 138-145. 
 
Vieth R, 2005. The pharmacology of vitamin D, including fortification strategies. In Feldman D, Pike 
JW, Glorieux FH, eds. Vitamin D. Elsevier Academic Press, San Diego, CA, USA, 2: 995-
1015 pp. 
 
Villanger GD, 2011. Effects of complex organohalogen contaminant mixtures on thyroid hormone 
homeostasis in selected arctic marine mammals. PhD Thesis, Norwegian University of 
Science and Technology. 
 
Wania F, Mackay D, 1995. A global distribution model for persistent organic chemicals. The Science 
of the Total Environment, 160: 211-232. 
 
Wiig O, Derocher AE, Cronin MM, Skaare JU, 1998. Female pseudohermaphrodite polar bears at 
Svalbard. Journal of Wildlife Diseases, 34: 792-796. 
 
	   	   	  	   	  
	   57	  
Wilske J, Arnbom T, 1996. Seasonal variation in vitamin D metabolites in southern elephant seal 
(Mirounga leonina) females at south Georgia. Comparative Biochemistry and Physiology, 
Part A: Physiology, 114: 9-14. 
 
Wold S, Sjöström M, Eriksson L, 2001. PLS-regression: A basic tool of chemometrics. Chemometrics 
and Intelligent Laboratory Systems, 58: 109-130. 
 
Yasuda H, Higashio K, Suda T, 2005. Vitamin D and osteoclastogenesis. In Feldman D, Pike JW, 
Glorieux FH, eds. Vitamin D. Elsevier Academic Press, San Diego, CA, USA, 665-685 pp. 
 
Yen PM, Chin WW, 1994. New advances in understanding the molecular mechanisms of thyroid 
hormone action. Trends in Endocrinology & Metabolism, 5: 65-72. 
 
Zoeller RT, 2007. Environmental chemicals impacting the thyroid: Targets and consequences. 
Thyroid, 17: 811-817. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   	   	  	   	  
	   58	  
 
 
 
 
 
 
 
  Appendices 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   	   	  	   	  
	   59	  
A. Sampling Information 
 
Table A.1: Date, sex, age and location (latitude and longitude) in female (FWCOY and FWOCOY) and male 
polar bears (Ursus maritimus) from Svalbard, sampled in 2008. 
 
ID Date Sex Latitude Longitude Age 
FWCOY 
     23958 24.04.08 F 78.21 21.94 5 
23689 13.04.08 F 79.21 15.85 5 
23781 20.04.08 F 77.05 16.99 8 
23966 25.04.08 F 77.75 18.48 14 
23962 25.04.08 F 77.34 17.77 12 
23703 21.04.08 F 78.58 21.00 15 
23909 14.04.08 F 79.33 13.93 12 
23924 09.04.08 F 79.49 17.96 10 
FWOCOY 
     23802 13.04.08 F 79.01 16.12 9 
23831 14.04.08 F 79.66 12.16 6 
23881 16.04.08 F 79.65 12.23 6 
23931 11.04.08 F 79.69 21.58 8 
23882 14.04.08 F 79.61 13.00 6 
23719 21.04.08 F 78.52 20.14 7 
23500 24.04.08 F 78.12 22.31 10 
23942 16.04.08 F 79.75 12.10 11 
23637 18.04.08 F 77.07 16.00 7 
23714 19.04.08 F 77.74 18.44 8 
23731 20.04.08 F 77.04 16.32 8 
23824 14.04.08 F 79.73 12.22 14 
23945 19.04.08 F 77.55 22.12 9 
23688 13.04.08 F 79.08 16.04 12 
23948 20.04.08 F 76.72 16.16 16 
Males 
     23834 13.04.08 M 79.30 15.80 9 
23683 14.04.08 M 79.63 12.81 6 
23921 08.04.08 M 80.62 19.80 11 
23922 08.04.08 M 80.25 23.70 8 
23682 13.04.08 M 79.01 16.12 16 
23946 19.04.08 M 77.77 18.52 15 
23686 14.04.08 M 79.54 12.60 7 
23949 20.04.08 M 76.72 16.16 10 
23960 24.04.08 M 77.39 18.03 15 
23575 25.04.08 M 77.46 18.16 12 
23830 09.04.08 M 79.97 18.40 13 
23899 20.04.08 M 77.04 16.32 13 
23825 14.04.08 M 79.45 13.22 14 
23820 14.04.08 M 79.63 14.10 16 
23809 13.04.08 M 79.10 16.18 17 
23702 21.04.08 M 78.58 20.87 21 
23855 25.04.08 M 77.73 18.42 15 
23609 11.04.08 M 79.69 21.58 19 
23898 21.04.08 M 78.58 20.87 10 
23934 11.04.08 M 79.77 20.24 4 
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B. Individual biometric measurement 
Table B.1: Individual biometric measurements of female (FWCOY and FWOCOY) and male polar bears 
(Ursus maritimus) from Svalbard, sampled in 2008. 
 
ID 
 
 
Head 
length 
(mm) 
Zygomatic 
width 
(mm) 
Estimated total 
body mass  
(TBM) 
BCI Zoologic 
length  
(cm) 
Straight 
length 
(cm) 
Axillary 
girth 
(cm) 
FWCOY 
       23958 329 186 153.0 144.34 195 183 108 
23689 346 196 158.9 147.48 215 205 101 
23781 346 196 194.9 162.38 209 195 118 
23966 349 203 183.2 157.85 208 197 113 
23962 342 199 186.6 159.12 200 191 117 
23703 336 201 165.1 150.06 208 189 110 
23909 351 199 260.5 183.88 212 201 136 
23924 335 200 139.3 137.55 204 191 99 
FWOCOY 
       23802 353 197 188.9 160.11 210 197 115 
23831 336 190 166.5 150.80 205 197 107 
23881 331 189 161.5 148.53 205 195 106 
23931 334 185 134.0 134.56 193 181 101 
23882 341 183 159.6 147.59 207 191 107 
23719 333 196 163.7 149.43 205 190 109 
23500 354 199 203.6 165.62 205 195 121 
23942 339 198 164.8 149.98 205 191 109 
23637 349 209 205.6 166.49 220 205 117 
23714 359 209 160.4 147.99 204 194 106 
23731 343 199 189.2 160.34 215 204 112 
23824 346 212 237.3 177.10 215 205 127 
23945 366 208 196.5 162.93 204 192 120 
23688 357 207 207.5 167.15 214 202 119 
23948 345 216 169.9 152.24 204 193 110 
Males 
       23834 422 226 367.3 209.95 255 236 146 
23683 377 215 254.9 182.57 231 216 127 
23921 387 258 467.9 227.64 243 225 174 
23922 384 227 280.1 189.50 234 214 135 
23682 439 280 539.3 238.58 263 246 176 
23946 408 245 337.9 203.55 245 224 145 
23686 400 242 304.8 196.06 251 232 133 
23949 380 230 273.3 187.87 237 225 128 
23960 399 288 494.4 232.11 266 245 168 
23575 388 257 346.1 205.33 237 224 147 
23830 408 250 344.1 204.96 246 227 145 
23899 392 258 412.1 218.38 247 232 158 
23825 415 269 408.0 217.80 256 240 153 
23820 427 277 513.8 235.10 266 252 168 
23809 405 259 384.5 213.13 248 226 155 
23702 398 253 407.5 217.56 244 232 157 
23855 404 265 436.8 222.62 245 229 165 
23609 358 251 346.0 205.26 240 222 148 
23898 405 275 441.5 223.76 264 246 157 
23934 403 267 441.5 223.76 257 246 157 
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C.  Individual 1,25(OH)2D concentrations 
	  
Table C.1: Individual serum 1,25(OH)2D measurements of female (FWCOY and FWOCOY) and male polar 
bears (Ursus maritimus) from Svalbard, sampled in 2008. 
 
ID 
 
1,25(OH)2D 
(nmol/L) 
ID 
 
1,25(OH)2D 
(nmol/L) 
FWCOY 
 
Males 
 23958 0.521 23834 1.031 
23689 0.326 23683 0.777 
23781 0.474 23921 0.859 
23966 1.517 23922 0.520 
23962 0.619 23682 0.258 
23703 1.266 23946 0.647 
23909 0.592 23686 0.472 
23924 1.171 23949 0.197 
FWOCOY 
 
23960 0.337 
23802 0.507 23575 0.675 
23831 0.669 23830 0.771 
23881 1.054 23899 0.705 
23931 0.904 23825 0.706 
23882 0.857 23820 0.314 
23719 0.488 23809 0.493 
23500 0.412 23702 0.582 
23942 0.738 23855 0.648 
23637 0.702 23609 0.373 
23714 0.626 23898 0.615 
23731 0.599 23934 0.202 
23824 0.641   
 23945 0.605   
 23688 0.779   
 23948 0.652     
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D.  Individual Thyroid hormone concentrations 
Table D.1: Individual concentrations of Thyroid hormones of female (FWCOY and FWOCOY) and male polar 
bears (Ursus maritimus) from Svalbard, sampled in 2008. 	  
ID 
 
TT4 
(nmol/L) 
FT4 
(pmol/L) 
TT3 
(nmol/L) 
FT3 
(pmol/L) 
FT3/TT3* 
(x100) 
FT4/TT4* 
(x100) 
TT3/TT4 
(x100) 
FWCOY               
23958 18.11 7.73 1.15 0.53 0.046 0.043 0.064 
23689 11.31 5.02 0.69 0.06 0.008 0.044 0.061 
23781 13.32 5.06 1.27 0.06 0.005 0.038 0.095 
23966 18.12 8.63 1.25 0.65 0.052 0.048 0.069 
23962 20.10 5.51 1.19 0.51 0.043 0.027 0.059 
23703 21.55 7.60 1.24 0.61 0.049 0.035 0.058 
23909 14.84 5.49 1.01 0.28 0.028 0.037 0.068 
23924 31.24 11.30 1.01 0.57 0.057 0.036 0.032 
FWOCOY               
23802 15.48 6.73 1.19 0.74 0.062 0.043 0.077 
23831 10.52 6.41 1.30 0.74 0.057 0.061 0.123 
23881 20.43 7.40 1.49 0.44 0.029 0.036 0.073 
23931 10.15 4.63 0.79 0.27 0.033 0.046 0.078 
23882 24.83 12.65 1.62 1.49 0.092 0.051 0.065 
23719 19.85 9.34 1.31 0.39 0.030 0.047 0.066 
23500 19.64 7.72 1.55 0.88 0.057 0.039 0.079 
23942 11.59 6.97 0.92 0.24 0.026 0.060 0.080 
23637 8.75 3.51 1.02 0.33 0.033 0.040 0.116 
23714 19.73 9.95 1.13 0.48 0.043 0.050 0.057 
23731 14.15 7.23 1.21 0.50 0.041 0.051 0.085 
23824 18.57 9.21 1.39 0.72 0.052 0.050 0.075 
23945 7.78 6.27 1.44 0.64 0.044 0.081 0.185 
23688 37.78 14.83 1.61 0.72 0.045 0.039 0.043 
23948 11.56 4.78 1.25 0.46 0.037 0.041 0.108 
Males 
 
            
23834 18.85 5.40 1.10 0.47 0.043 0.029 0.059 
23683 9.77 5.40 1.34 0.70 0.053 0.055 0.137 
23921 6.29 6.41 0.77 0.15 0.020 0.102 0.123 
23922 12.73 4.82 1.09 0.53 0.048 0.038 0.085 
23682 4.15 3.13 0.60 0.06 0.010 0.075 0.146 
23946 6.56 3.36 1.01 0.06 0.006 0.051 0.154 
23686 10.27 7.31 0.74 0.18 0.024 0.071 0.072 
23949 5.37 4.26 0.52 0.06 0.011 0.079 0.096 
23960 5.76 3.00 0.64 0.06 0.009 0.052 0.112 
23575 13.99 4.04 1.03 0.31 0.030 0.029 0.073 
23830 9.28 3.15 0.70 0.06 0.008 0.034 0.075 
23899 6.67 3.28 0.60 0.06 0.010 0.049 0.091 
23825 12.21 6.49 0.83 0.06 0.007 0.053 0.068 
23820 6.15 4.08 0.57 0.06 0.010 0.066 0.093 
23809 15.30 5.62 1.02 0.29 0.029 0.037 0.066 
23702 15.51 8.58 0.96 0.41 0.043 0.055 0.062 
23855 8.00 4.50 0.93 0.23 0.024 0.056 0.116 
23609 1.33 1.51 0.68 0.06 0.009 0.114 0.514 
23898 7.08 4.52 0.74 0.19 0.026 0.064 0.104 
23934 8.63 3.82 0.76 0.23 0.029 0.044 0.089 
* FT3 and FT4 were converted to nmol/L before calculation of ratio. 
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E. Thyroid concentrations w
ith significant differences betw
een groups 
 T
able E
.1 : M
ean (X
) concentrations of 1,25(O
H
)2D
 (nm
ol/L), cholesterol (m
m
ol/L), lipid content (%
), total (nm
ol/L) and free (pm
ol/L) T4 and T3, and FT3:TT3, FT4:TT4, 
TT3:TT4 m
ole ratios (x100) ± standard deviaton (SD
) and range (m
in – m
ax), m
easured in serum
 from
 three groups of polar bears (U
rsus m
aritim
us) from
 Svalbard in 2008, 
w
ith F-statistics and significance level (p) from
 analysis of variance. For significant differences, p-values are given in bold. 
 
1 total thyroxine 
2 free thyroxine 
3 total triiodothyronine 
4 free triiodothyronine 
a,b different letters denote significant differences betw
een groups 
    !
FW
C
O
Y
 (n=8) 
FW
O
C
O
Y
 (n=15) 
M
ales (n=20) 
A
N
O
V
A
 
  
X
 ± SD
 
M
edian 
M
in - M
ax 
X
 ± SD
 
M
edian 
M
in - M
ax 
X
 ± SD
 
M
edian 
M
in - M
ax 
F 
p 
1,25(O
H
)2D
 (nm
ol/L) 
0.81 ± 0.43 
0.61 
0.33 – 1.52 
0.68 ± 0.16 
0.65 
0.41 – 1.05 
0.56 ± 0.23 
0.59 
0.19 – 1.03 
2.76 
 0.076 
C
holesterol (m
m
ol/L) 
9.24 ± 1.98
a 
9.25 
5.40 – 11.50 
9.02 ± 1.61
a 
9.1 
5.7 – 13.10 
6.29 ± 1.19
b 
6.25  
3.9 – 8.3 
 18.53 
 < 0.001 
Lipid (%
) 
1.30 ± 0.23
a 
1.21 
1.0 – 1.59 
1.34 ± 0.21
a 
1.36 
0.82 – 1.56 
0.82 ± 0.17
b 
 0.79 
0.56 – 1.22 
 35.44 
 < 0.001 
TH
s 
!!
!!
!!
!!
!!
!!
!!
!!
!!
  
  
TT4
1 (nm
ol/L) 
18.57 ± 6.16
a 
18.12 
11.31 – 31.24 
16.71 ± 7.74
a 
15.48 
7.78 – 37.78 
9.19 ± 4.39
b 
8.31 
1.33 – 18.85 
 9.93 
 < 0.001 
FT4
2 (pm
ol/L) 
7.04 ± 2.21
a 
6.56 
5.02 – 11.30 
7.84 ± 2.99
a 
7.23 
3.51 – 14.83 
4.63 ± 1.67
b 
4.38 
1.51 – 8.58 
 8.90 
 0.001 
TT3
3 (nm
ol/L) 
1.10 ± 0.19
a 
1.17 
0.69 – 1.27 
1.28 ± 0.24
a,b 
1.3 
0.79 – 1.62 
0.83 ± 0.21
b 
0.77 
0.52 – 1.34 
 17.59 
 < 0.001 
FT3
4 (pm
ol/L) 
0.40 ± 0.24
a 
0.52 
0.06 – 0.65 
0.60 ± 0.31
a,b 
0.5 
0.24 – 1.49 
0.21 ± 0.18
b 
0.17 
0.06 – 0.70 
 10.72 
 < 0.001 
FT3:TT3 
0.03 ± 0.02
a,b 
0.04 
0.01 – 0.06 
0.04 ± 0.01
a 
0.04 
0.03 – 0.09 
0.02 ± 0.01
b 
0.02 
0.01 – 0.05 
 8.26 
 < 0.001 
FT4:TT4 
0.03 ± 0.01
a 
0.04 
0.03 – 0.05 
0.04 ± 0.01
a,b 
0.05 
0.04 – 0.08 
0.05 ± 0.02
b 
0.05 
0.03 – 0.11 
 3.74 
 0.032 
TT3:TT4 
0.06 ± 0.01 
0.06 
0.03 – 0.10 
0.08 ± 0.03 
0.08 
0.04 – 0.18 
0.11 ± 0.09 
0.09 
0.06 – 0.51 
 1.83 
 0.173 
!
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F. Contam
inant concentrations w
ith significant differences betw
een groups  
 T
able F.1: C
oncentrations of contam
inant com
pounds (nm
ol/L) in plasm
a of Svalbard fem
ale polar bears (U
rsus m
aritim
us) w
ith cubs of the year (FW
C
O
Y
) fem
ales w
ithout 
cubs of the year (FW
O
C
O
Y
) and m
ales. N
 denotes the num
ber of observations per variable. For significant differences, p-values are given in bold. 
 
  
  
Fem
ales W
C
O
Y
 (n=8) 
Fem
ales W
O
C
O
Y
 (n=15) 
M
ales (n=20) 
A
N
O
V
A
 
A
nalyte (nm
ol/L
) 
       X
 ± SD
              M
edian           M
in - M
ax 
X
 ± SD
 
M
edian 
M
in - M
ax 
X
 ± SD
 
M
edian 
M
in - M
ax 
F 
p 
Pesticides 
oxychlordane 
34.4 ± 35.7
a 
23.7 
   7.26 - 118 
30.4 ± 20.8
a 
26.3 
10.9 - 97.1 
3.89 ± 2.65
b 
2.99 
1.21 - 11.3 
53.8 
< 0.00 
  
trans-nonachlor 
1.23 ± 0.96 
1.19 
0.06 - 3.13 
1.49 ± 0.99 
1.39 
0.34 - 3.69 
1.08 ± 0.77 
0.93 
0.32 - 3.10 
0.69 
0.509 
  
M
irex 
0.23 ± 0.14
a 
0.17 
0.13 - 0.55 
0.18 ± 0.07
a,b 
0.19 
0.07 - 0.32 
0.13 ± 0.04
b 
0.14 
0.03 - 0.24 
3.74 
0.032 
  
H
C
B
 
3.23 ± 2.62 
1.87 
1.05 - 8.62 
3.56 ± 3.00 
2.72 
1.01 - 12.9 
5.57 ± 4.77 
3.86 
0.92 - 18.9 
1.31 
0.281 
  
!-H
C
H
 
0.08 ± 0.04 
0.09 
0.02 - 0.16 
0.12 ± 0.04 
0.11 
<0.00 - 0.20 
0.07 ± 0.02 
0.08 
<0.00 - 0.13 
1.51 
0.233 
  
"-H
C
H
 
0.72 ± 0.42 
0.56 
0.35 - 1.57 
0.81 ± 0.46 
0.70 
0.37 - 2.24 
1.07 ± 0.70 
0.84 
0.33 - 3.39 
1.72 
0.193 
  
p,p'-D
D
T 
0.32 ± 0.31 
0.26 
0.01 - 0.85 
0.32 ± 0.44 
0.16 
0.01 - 1.35 
0.30 ± 0.48 
0.09 
<0.00 - 1.83 
0.09 
0.912 
  
p,p'-D
D
E 
1.05 ± 2.01 
0.35 
0.10 - 6.02 
0.81 ± 0.43 
0.62 
0.25 - 1.80 
0.80 ± 0.67 
0.49 
0.24 - 2.62 
1.03 
0.367 
  
#pesticides 1 
41.2 ± 41.9
a 
28.2 
9.83 - 138 
37.7 ± 25.6
a 
31.8 
13.3 - 118 
12.9 ± 9.68
b 
9.26 
3.06 - 39.3 
7.05 
0.002 
PC
B
s 
PC
B
-47 
0.53 ± 0.46 
0.41 
0.13 - 1.51 
0.55 ± 0.34 
0.52 
0.14 - 1.53 
0.54 ± 0.48 
0.34 
0.11 - 1.59 
0.32 
0.726 
  
PC
B
-74 
0.38 ± 0.14 
0.39 
0.22 - 0.58 
0.33 ± 0.08 
0.36 
0.20 - 0.55 
0.31 ± 0.12 
0.32 
0.04 - 0.62 
0.89 
0.417 
  
PC
B
-99 
12.0 ± 12.5 
7.90 
3.41 - 41.3 
11.70 ± 7.20 
10.1 
3.79 - 31.0 
7.93 ± 5.31 
5.86 
2.03 - 20.1 
2.01 
0.148 
  
PC
B
-101 
0.22 ± 0.24 
0.18 
<0.00 - 0.80 
0.21 ± 0.11 
0.21 
0.06 - 0.54 
0.17 ± 0.11 
0.18 
0.03 - 0.37 
0.90 
0.413 
  
PC
B
-105 
 0.24 ± 0.15  
0.23 
0.05 - 0.46 
0.20 ± 0.10 
0.20 
0.09 - 0.51 
1.00 ± 3.10 
0.28 
0.10 - 14.2 
2.88 
0.068 
  
PC
B
-114 
0.07 ± 0.03 
0.08 
0.01 - 0.13 
0.07 ± 0.04 
0.07 
0.04 - 0.20 
0.06 ± 0.01 
0.06 
0.05 - 0.12 
0.62 
0.542 
  
PC
B
-118 
1.23 ± 0.66 
1.13 
0.33 - 2.19 
1.19 ± 0.42 
1.19 
0.50 - 2.06 
1.30 ± 0.69 
1.07 
0.72 - 3.64 
0.25 
0.782 
  
PC
B
-128 
0.13 ± 0.11 
0.08 
0.01 - 0.31 
0.14 ± 0.10 
0.13 
<0.00 - 0.37 
0.12 ± 0.09 
0.09 
0.01 - 0.30 
0.31 
0.738 
  
PC
B
-137 
1.15 ± 1.16 
0.80 
0.30 - 3.87 
1.13 ± 0.67 
1.02 
0.28 - 2.68 
0.68 ± 0.42 
0.52 
0.23 - 1.71 
2.91 
0.066 
  
PC
B
-138 
9.66 ± 10.1 
7.52 
1.72 - 32.8 
10.7 ± 6.79 
8.43 
3.95 - 25.8 
8.35 ± 5.79 
6.19 
2.68 - 23.3 
0.96 
0.392 
  
PC
B
-153 
60.4 ± 68.7 
33.2 
13.7 - 223 
58.2 ± 36.4 
48.7 
27.8 - 162 
48.3 ± 36.1 
34.6 
13.8 - 148 
0.70 
0.503 
  
PC
B
-156 
2.56 ± 2.80 
1.53 
0.83 - 9.29 
2.21 ± 1.48 
1.83 
0.56 - 6.34 
2.09 ± 1.27 
1.71 
0.39 - 5.61 
0.03 
0.973 
  
PC
B
-157 
1.66 ± 1.94 
0.81 
0.51 - 6.34 
1.57 ± 1.41 
1.04 
0.44 - 5.86 
2.11 ± 1.18 
1.77 
0.82 - 4.86 
2.56 
0.090 
  
PC
B
-167 
0.06 ± 0.03 
0.06 
0.02 - 0.12 
0.05 ± 0.04 
0.05 
0.01 - 0.17 
0.04 ± 0.04 
0.05 
<0.00 - 0.17 
1.26 
0.295 
  
PC
B
-170 
14.7 ± 16.3 
7.72 
3.65 - 53.1 
15.0 ± 12.3 
12.6 
5.46 - 54.5 
17.0 ± 12.9 
12.2 
5.82 - 53.6 
0.66 
0.521 
  
PC
B
-180 
36.8 ± 43.5 
19.6 
9.39 - 140 
35.0 ± 21.1 
26.6 
14.2 - 87.8 
28.7 ± 21.8 
20.9 
8.93 - 89.0 
0.67 
0.516 
  
PC
B
-183 
0.99 ± 1.13
a,b 
0.69 
0.16 - 3.65 
1.00 ± 0.59
a 
0.87 
0.44 - 2.42 
0.57 ± 0.40
b 
0.42 
0.14 - 1.45 
3.48 
0.041 
  
PC
B
-187 
0.19 ± 0.14 
0.17 
0.04 - 0.47 
0.22 ± 0.11 
0.19 
0.08 - 0.46 
0.14 ± 0.10 
0.1 
0.04 - 0.41 
2.53 
0.093 
  
PC
B
-189 
0.39 ± 0.37 
0.25 
0.14 - 1.28 
0.38 ± 0.25 
0.32 
0.13 - 1.23 
0.55 ± 0.37 
0.44 
0.18 - 1.35 
1.74 
0.189 
  
PC
B
-194 
9.74 ± 7.99 
6.97 
3.89 - 27.4 
8.45 ± 3.98 
8.05 
3.62 - 18.2 
9.22 ± 5.51 
6.73 
3.88 - 24.4 
0.04 
0.958 
  
PC
B
-206 
1.70 ± 1.12 
1.31 
0.43 - 3.54 
1.51 ± 0.59 
1.55 
0.61 - 2.64 
1.36 ± 0.73 
1.07 
0.81 - 3.33 
0.32 
0.731 
  
#PC
B
s 2 
155 ± 167 
86.9 
40.5 - 550 
150 ± 91.2 
116 
68.0 - 405 
131 ± 88.7 
91.9 
51.0 - 379 
0.21 
0.812 
	   	   	  	   	  
	   65	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  T
able F.1. C
ontinued 
 
1 !pesticides include oxychlordane, trans-N
onachlor, M
irex, H
C
B
, "-H
C
H
 and #-H
C
H
, p,p'-D
D
T and p,p'-D
D
E 
2 !PC
B
s the 21 PC
B
 congeners, PC
B
 – 47, -74, -99,  -101, -105, -114, -118, -128, -137, -138, -153, 156, -157, -167, -170, -180, -183, -187, -189, -194 and -206. 
3 !O
H
-PC
B
s  include the 8 m
etabolites: 4-O
H
-C
B
107, 4'-O
H
-C
B
130, 3'-O
H
-C
B
138, 4-O
H
-C
B
146, 4'-O
H
-C
B
159, 4'-O
H
-C
B
172, 3'-O
H
-C
B
180, 4-O
H
-C
B
187 
4 !PB
D
Es include the congeners B
D
E -47, -153, -154, -183 and -209. 
a,b different letters denote significant differences betw
een groups.
  
  
Fem
ales W
C
O
Y
 (n=8) 
Fem
ales W
O
C
O
Y
 (n=15) 
M
ales (n=20) 
A
N
O
V
A
 
A
nalyte (nm
ol/L
) 
       X
 ± SD
              M
edian           M
in - M
ax 
X
 ± SD
 
M
edian 
M
in - M
ax 
X
 ± SD
 
M
edian 
M
in - M
ax 
F 
p 
O
H
-PC
B
s 
4-O
H
-C
B
107 
15.8 ± 13.6 
12.0 
1.83 - 42.7 
9.41 ± 4.97 
8.61 
1.83 - 17.42 
13.44 ± 8.39 
9.40 
4.71 - 35.8 
0.93 
0.403 
  
4'-O
H
-C
B
130 
0.51 ± 0.53 
0.24 
0.21 - 1.47 
0.42 ± 0.18 
0.39 
0.20 - 0.75 
0.51 ± 0.27 
0.47 
0.18 - 1.00 
0.27 
0.764 
  
3'-O
H
-C
B
138 
1.71 ± 1.19
a 
1.66 
0.52 - 4.32 
2.11 ± 1.08
a,b 
1.95 
0.91 - 4.50 
3.24 ± 2.13
b 
2.71 
1.19 - 10.2 
4.72 
0.015 
  
4-O
H
-C
B
146 
75.4 ± 41.9
a 
75.2 
16.4 - 137 
66.1 ± 20.2
a 
68.7 
22.0 - 93.5 
31.1 ± 21.7
b 
22.4 
12.6 - 81.9 
11.4 
< 0.00 
  
4'-O
H
-C
B
159 
2.00 ± 2.63
a 
0.83 
0.50 - 8.25 
0.59 ± 0.28
b 
0.51 
0.19 - 1.13 
0.66 ± 0.33
b 
0.64 
0.26 - 1.54 
5.03 
0.012 
  
4'-O
H
-C
B
172 
43.9 ± 31.5 
41.8 
7.45 - 99.8 
46.9 ± 14.3 
47.5 
21.9 - 74.3 
60.3 ± 19.8 
66.8 
15.6 - 91.9 
2.95 
0.065 
  
3'-O
H
-C
B
180 
2.43 ± 1.00
a 
2.31 
1.26 - 4.60 
2.34 ± 1.02
a 
2.09 
1.05 - 4.72 
5.58 ± 3.22
b 
4.06 
2.36 - 12.99 
13.2 
< 0.00 
  
4-O
H
-C
B
187 
137 ± 88.2 
134 
24.6 - 260 
126 ± 52.0 
136 
33.8 - 210 
78.5 ± 62.2 
50.2 
19.9 - 234 
3.57 
0.038 
  
!O
H
-PC
B
s 3 
279 ± 151 
302 
57.2 - 484 
254 ± 82.4 
264 
83.7 - 378 
225 ± 104 
211 
81.9 - 407 
2.28 
0.116 
PB
D
E
s 
B
D
E-47 
0.49 ± 0.31
a 
0.44 
0.11 - 0.99 
0.43 ± 0.25
a 
0.37 
0.18 - 1.17 
0.18 ± 0.12
b 
0.13 
0.06 - 0.42 
11.1 
< 0.00 
  
B
D
E-153 
0.11 ± 0.05 
0.10 
0.05 - 0.20 
0.13 ± 0.06 
0.13 
0.05 - 0.30 
0.10 ± 0.04 
0.11 
0.04 - 0.17 
1.28 
0.291 
  
B
D
E-154 
0.23 ± 0.23 
0.15 
0.06 - 0.80 
0.21 ± 0.13 
0.18 
0.08 - 0.63 
0.17 ± 0.12 
0.14 
0.06 - 0.55 
0.71 
0.497 
  
B
D
E-183 
0.16 ± 0.19 
0.08 
0.03 - 0.58 
0.40 ± 0.37 
0.2 
0.05 - 1.04 
0.30 ± 0.27 
0.28 
0.04 - 1.01 
1.78 
0.181 
  
B
D
E-209 
0.04 ± 0.01 
0.05 
0.02 - 0.07 
0.04 ± 0.03 
0.03 
0.01 - 0.10 
0.06 ± 0.05 
0.05 
0.01 - 0.21 
1.48 
0.240 
  
!PB
D
Es 4 
0.96 ± 0.63
a 
0.93 
0.15 - 2.12 
1.22 ± 0.54
b 
1.02 
0.33 - 2.07 
0.87 ± 0.32
a 
0.89 
0.30 -1.39 
3.17 
0.053 
!!!
